syndrome	score	normalized_score
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	1.4947465399999997	100.0
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.1	73.59107183482762
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	1.0951250099999998	73.26493025366027
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	1.03916258	69.52098915713162
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.0172660199999999	68.05608795722652
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	68.05444085523692
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	1.0126582	67.74782030938839
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	1.00775862	67.42003363326067
SENGERS SYNDROME	1.00684932	67.35920057724303
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	1.00378788	67.15438725819028
OCULOSKELETODENTAL SYNDROME; OCSKD	1.0021768739999999	67.04660938703361
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	67.01011129284836
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	66.90097439529782
CARIBBEAN PARKINSONISM	1.0	66.90097439529782
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.0	66.90097439529782
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	1.0	66.90097439529782
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	62.4408871352865
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.694064814	46.433612350091146
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.667968984	44.687775895437106
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.6581513040000001	44.03096353713588
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.646756484	43.26863897607684
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.583333	39.02554609693227
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.5588235	37.38583666499072
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.5588235	37.38583666499072
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.5169492	34.584405192869696
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.514244154	34.40343497968559
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.512593754	34.29302161154359
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.5104167	34.147374577632405
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.50775862	33.96954643561176
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.504855894	33.77535123780919
BARTH SYNDROME; BTHS	0.50344828	33.68118048963673
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.501301984	33.537591195896006
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.50075643	33.50109310171075
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.500545554	33.486985291834166
NOONAN SYNDROME 7; NS7	0.5	33.45048719764891
RENAL TUBULAR ACIDOSIS III	0.5	33.45048719764891
BRANCHIOOTORENAL SYNDROME 1	0.5	33.45048719764891
GLYCINE ENCEPHALOPATHY	0.5	33.45048719764891
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	32.03135027828866
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.42328116	28.31792204717196
RFT1-CDG	0.417968284	27.96248546593057
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.416667	27.875428298365563
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.405921894	27.156570236984802
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.40551519999999996	27.129362012104075
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.40463252999999993	27.070310529034575
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.393402554	26.319014192198768
PLACENTAL INSUFFICIENCY	0.3768113	25.209043133158886
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	23.4537689580469
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.34999969999999997	23.415320968061916
ACUTE ADRENAL INSUFFICIENCY	0.3470316	23.216752185959237
DILATED CARDIOMYOPATHY WITH ATAXIA	0.34449266	23.04689462602804
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.338422864	22.64081935924736
CANAVAN DISEASE	0.33764334	22.588668444082842
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33572074999999996	22.46004529972018
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333878554	22.336800592293063
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.333878554	22.336800592293063
EPIDERMAL NEVUS SYNDROME	0.333878554	22.336800592293063
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.333333	22.30030249810781
NEUROMYELITIS OPTICA	0.333333	22.30030249810781
ENCEPHALITIS LETHARGICA	0.333333	22.30030249810781
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	22.30030249810781
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	22.30030249810781
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	22.30030249810781
MYOCLONUS AND ATAXIA	0.333333	22.30030249810781
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	22.30030249810781
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	22.30030249810781
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333333	22.30030249810781
ADDISON DISEASE	0.333333	22.30030249810781
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	22.30030249810781
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	22.30030249810781
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333333	22.30030249810781
MACHADO-JOSEPH DISEASE TYPE 1	0.325	21.742816678471794
MACHADO-JOSEPH DISEASE TYPE 3	0.325	21.742816678471794
MACHADO-JOSEPH DISEASE TYPE 2	0.325	21.742816678471794
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.323961124	21.6733148617959
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.3215277	21.510516425079
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.310069554	20.743955292915416
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	20.07029231858935
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.28834590000000004	19.29062167288911
AL KAISSI SYNDROME; ALKAS	0.287428394	19.229239627475575
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27446538	18.362001359775686
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.263203754	17.60858760710027
HSD10 DISEASE	0.259060604	17.33140683503439
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2588235	17.315544346401364
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.255625154	17.101571882548065
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.253993834	16.992434984997526
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.25282635999999997	16.91432983681635
INFANTILE MYOFIBROMATOSIS	0.2522581	16.876312689106477
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.252176874	16.870878590560245
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.251301984	16.812347597071543
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.251301984	16.812347597071543
MOWAT-WILSON SYNDROME; MOWS	0.25075643	16.775849502886288
SECKEL SYNDROME 1; SCKL1	0.25075643	16.775849502886288
BIOTINIDASE DEFICIENCY	0.250545554	16.76174169300971
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	16.76174169300971
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250545554	16.76174169300971
INHERITED CREUTZFELDT-JAKOB DISEASE	0.2500003	16.725263669116774
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	16.725243598824456
DYSTONIA 6, TORSION	0.25	16.725243598824456
HYPERPARATHYROIDISM 2	0.25	16.725243598824456
CONGENITAL FACTOR II DEFICIENCY	0.25	16.725243598824456
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.725243598824456
SPINOCEREBELLAR ATAXIA TYPE 2	0.25	16.725243598824456
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25	16.725243598824456
HEMOPHILIA B	0.25	16.725243598824456
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.25	16.725243598824456
SEVERE HEMOPHILIA A	0.25	16.725243598824456
POSTENCEPHALITIC PARKINSONISM	0.25	16.725243598824456
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.24361343	16.29797584278068
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.24281650000000002	16.244660449255836
HYDRANENCEPHALY	0.23502835400000002	15.723625893122994
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.230303	15.407495106160276
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	14.90067339443382
JUVENILE HYALINE FIBROMATOSIS	0.22	14.71821436696552
6P22 MICRODELETION SYNDROME	0.21858052	14.623249771830885
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.21389157	14.309554447940053
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.21369860000000002	14.296644566910993
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.21357487400000003	14.288367176952962
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.21265820000000002	14.227040793150126
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.21265820000000002	14.227040793150126
TRICHOTHIODYSTROPHY	0.209829854	14.037821689823083
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.20903873	13.984894723355575
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.20740741000000001	13.875757825805039
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.207394874	13.87491915519002
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.20684932	13.838421061004766
AICARDI-GOUTIÈRES SYNDROME	0.205612324	13.755664823281682
RHEUMATIC FEVER	0.20344828	13.610888171047383
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.202176874	13.525829870795356
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20075643	13.430800783121402
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	13.416692973244817
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	13.380194879059564
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	13.380194879059564
SHOX-RELATED SHORT STATURE	0.2	13.380194879059564
ROMANO-WARD SYNDROME	0.2	13.380194879059564
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	13.380194879059564
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	13.380194879059564
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	13.380194879059564
BETA-THALASSEMIA	0.2	13.380194879059564
BENIGN SCHWANNOMA	0.2	13.380194879059564
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.2	13.380194879059564
MEDULLARY SPONGE KIDNEY	0.2	13.380194879059564
MALARIA	0.2	13.380194879059564
SYDENHAM CHOREA	0.2	13.380194879059564
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	13.380194879059564
POLYARTERITIS NODOSA	0.2	13.380194879059564
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.19191897400000002	12.83956636554583
HUNTINGTON DISEASE-LIKE 1	0.1910572	12.781912845237297
ETHYLMALONIC ENCEPHALOPATHY	0.18827569	12.595827115947031
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.18523407	12.392339774206805
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.180390374	12.068291792132198
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.1785713	11.946593969035046
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.178565144	11.94618212663667
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.1773398	11.864205419067236
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.1773398	11.864205419067236
MUCOLIPIDOSIS TYPE II	0.17570573	11.754884543837113
HUNTINGTON DISEASE-LIKE 2	0.17338278	11.599476925365556
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.170480054	11.405281727562992
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.17011528	11.380877991528921
CEREBROOCULONASAL SYNDROME	0.16829832	11.25932159709164
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.167212554	11.186682793726357
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	11.150184699541104
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	11.150184699541104
PFAPA SYNDROME	0.166667	11.150184699541104
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	11.150184699541104
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	11.150184699541104
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	11.150184699541104
DERMATOLEUKODYSTROPHY	0.166667	11.150184699541104
PEMPHIGUS VULGARIS	0.166667	11.150184699541104
PITYRIASIS RUBRA PILARIS	0.166667	11.150184699541104
PITUITARY APOPLEXY	0.166667	11.150184699541104
DE BARSY SYNDROME	0.15873247399999998	10.619357178776276
WRINKLY SKIN SYNDROME	0.15873247399999998	10.619357178776276
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.15276696	10.220258479407487
EHLERS-DANLOS SYNDROME, TYPE VI	0.14827619999999997	9.919822259632058
MANGANESE POISONING	0.14630527999999998	9.787965791176878
GITELMAN SYNDROME	0.14545450000000001	9.731047780180848
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.14486227999999998	9.691427685124463
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.144158984	9.644376497436149
PHACE SYNDROME	0.144158984	9.644376497436149
XQ12-Q13.3 DUPLICATION SYNDROME	0.14405445	9.63738307097871
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14361343	9.607878403250895
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.143402554	9.593770593374314
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	9.557272499189061
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	9.557272499189061
GANGLIONEUROMA	0.14285699999999998	9.557272499189061
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.14285699999999998	9.557272499189061
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	9.557272499189061
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	9.557272499189061
JUVENILE HUNTINGTON DISEASE	0.14285699999999998	9.557272499189061
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	9.557272499189061
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.13837934999999998	9.257713351187956
COFFIN-SIRIS SYNDROME 1; CSS1	0.134635184	9.00722499749021
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.13351995	8.932614756211446
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.13311061400000002	8.905229778956373
DERMATOMYOSITIS	0.1324787	8.862954116622342
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.1324787	8.862954116622342
NEUROFIBROMATOSIS TYPE 1	0.1324787	8.862954116622342
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.13000834	8.697684625515175
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.12897576	8.628604017374077
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	8.471228841245553
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.1266234	8.471228841245553
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.1266234	8.471228841245553
PULMONARY ARTERIOVENOUS MALFORMATION	0.1266234	8.471228841245553
PARKINSON DISEASE, LATE-ONSET; PD	0.125	8.362621799412228
DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES	0.125	8.362621799412228
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.125	8.362621799412228
PARKINSONIAN-PYRAMIDAL SYNDROME	0.125	8.362621799412228
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1243902	8.321825585225975
OCULOCEREBRORENAL SYNDROME OF LOWE	0.12351602	8.263342091429095
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	8.130321546019434
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	8.130321546019434
GALACTOSEMIA	0.12152769999999999	8.130321546019434
HEREDITARY METHEMOGLOBINEMIA	0.11927484	7.979603016843244
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.11887508999999999	7.9528593523287245
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.11851840999999999	7.928997112781409
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.11840265400000001	7.921252923589309
RABSON-MENDENHALL SYNDROME	0.11840265400000001	7.921252923589309
CHILDHOOD APRAXIA OF SPEECH	0.11800754999999999	7.894820081001827
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11796991400000001	7.892302195929488
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.1169231	7.822269319318847
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.11596689399999999	7.7582982061962165
PYRUVATE CARBOXYLASE DEFICIENCY	0.11443712400000002	7.655955102595523
OKAMOTO SYNDROME	0.112412984	7.520538164283024
PETERS-PLUS SYNDROME; PTRPLS	0.112412984	7.520538164283024
CHROMOSOME 16P13.3 DELETION SYNDROME	0.112412984	7.520538164283024
WARBURG MICRO SYNDROME 1	0.11186742999999999	7.4840400700977705
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.11186742999999999	7.4840400700977705
SPEECH-LANGUAGE DISORDER 1	0.11111110000000002	7.433440856133378
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	7.433434166035936
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.11111099999999999	7.433434166035936
PORPHYRIA CUTANEA TARDA	0.11111099999999999	7.433434166035936
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	7.433434166035936
HUNTINGTON DISEASE-LIKE 3	0.11111099999999999	7.433434166035936
MOHR-TRANEBJAERG SYNDROME	0.11111099999999999	7.433434166035936
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.11111099999999999	7.433434166035936
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.11111099999999999	7.433434166035936
ZIMMERMANN-LABAND SYNDROME	0.11111099999999999	7.433434166035936
FACIAL HYPERTRICHOSIS	0.11111099999999999	7.433434166035936
ENTERIC ANENDOCRINOSIS	0.11111099999999999	7.433434166035936
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	7.386984819513281
FAMILIAL HYPOALDOSTERONISM	0.1104167	7.386984819513281
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.10758780400000001	7.197728920650322
WERNER SYNDROME	0.1023018	6.844090102392879
MELAS	0.10229164000000002	6.843410388493024
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.10130198400000001	6.7772014377768715
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.10130198400000001	6.7772014377768715
SAY SYNDROME	0.10075643000000001	6.740703343591618
PALLISTER-HALL SYNDROME	0.10054555400000001	6.726595533715035
NARP SYNDROME	0.10054555400000001	6.726595533715035
LOWE OCULOCEREBRORENAL SYNDROME	0.1	6.690097439529782
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	6.690097439529782
X-LINKED ACROGIGANTISM	0.1	6.690097439529782
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	6.690097439529782
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	6.690097439529782
HUNTINGTON DISEASE-LIKE 1	0.09599150000000001	6.4219248836662315
SALT-AND-PEPPER SYNDROME	0.09567534400000001	6.400773739205312
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.09503851400000002	6.358169191681156
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.0945378	6.324670937187787
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	6.242282387219978
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.09157110000000002	6.126195816449258
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.091520524	6.122812232768241
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09142860000000001	6.1166624275979276
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0910816	6.093447789482758
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09092110400000002	6.0827104506962115
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0909091	6.08190737139957
ARTERIAL TORTUOSITY SYNDROME	0.0909091	6.08190737139957
MALIGNANT ATROPHIC PAPULOSIS	0.0909091	6.08190737139957
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0909091	6.08190737139957
HISTIOCYTOID CARDIOMYOPATHY	0.09037555000000001	6.046212356510959
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09037555000000001	6.046212356510959
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.09037555000000001	6.046212356510959
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08818919400000001	5.899943009735954
ADNP SYNDROME	0.08639897999999999	5.780175948759848
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08551017400000001	5.720713961311462
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08463528400000002	5.662182967822761
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.08463528400000002	5.662182967822761
BETA-KETOTHIOLASE DEFICIENCY	0.08393272	5.615180751647702
PETTIGREW SYNDROME	0.08387885400000002	5.611577063760926
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.08387885400000002	5.611577063760926
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.08355690999999998	5.590038696460204
KEARNS-SAYRE SYNDROME; KSS	0.08355618000000001	5.589989858748897
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08334469000000001	5.575840971674036
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.08334469000000001	5.575840971674036
DPM3-CDG	0.08333330000000001	5.5750789695756735
STORMORKEN SYNDROME; STRMK	0.08333330000000001	5.5750789695756735
RAVINE SYNDROME	0.08333330000000001	5.5750789695756735
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	5.5750789695756735
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08333330000000001	5.5750789695756735
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.08224530000000001	5.502290709433589
FAMILIAL THROMBOCYTOSIS	0.0791926	5.298062104897062
PEDIATRIC-ONSET GRAVES DISEASE	0.07822508400000001	5.233334341754023
TRISOMY 8P	0.07767953000000001	5.19683624756877
GLYCEROL KINASE DEFICIENCY; GKD	0.077628954	5.1934526638877525
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.077628954	5.1934526638877525
N SYNDROME	0.07746865400000001	5.182728437692187
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	5.146230343506935
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	5.146230343506935
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.07692310000000001	5.146230343506935
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	5.146230343506935
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.07692310000000001	5.146230343506935
PAPILLARY TUMOR OF THE PINEAL REGION	0.07692310000000001	5.146230343506935
PINEOCYTOMA	0.07692310000000001	5.146230343506935
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	5.146230343506935
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	5.146230343506935
DERMOODONTODYSPLASIA	0.07692310000000001	5.146230343506935
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	5.146230343506935
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	5.146230343506935
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	5.146230343506935
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	5.146230343506935
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	5.146230343506935
DDOST-CDG	0.07692310000000001	5.146230343506935
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07631254999999999	5.105383953589885
GAPO SYNDROME	0.0757727	5.069267462562584
CONGENITAL ANALBUMINEMIA	0.07573640000000001	5.066838957192035
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.074254504	4.96769867083954
LYSOSOMAL ACID LIPASE DEFICIENCY	0.073067654	4.888297249378481
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.07273058400000001	4.865746937939059
WOLCOTT-RALLISON SYNDROME	0.07250273	4.850503283319192
3MC SYNDROME 1	0.07218503000000001	4.829248843753806
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07218503000000001	4.829248843753806
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07197415400000001	4.815141033877223
3MC SYNDROME 2	0.07197415400000001	4.815141033877223
3MC SYNDROME 3	0.07142860000000001	4.778642939691971
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07142860000000001	4.778642939691971
3MC SYNDROME	0.07142860000000001	4.778642939691971
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	4.778642939691971
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07142860000000001	4.778642939691971
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	4.778642939691971
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.07053025400000001	4.718542716947853
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07036015000000001	4.707162593599315
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07019710000000001	4.696254389724162
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.069686784	4.66211375207465
YOU-HOOVER-FONG SYNDROME; YHFS	0.06927438400000001	4.63452379023403
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.067968684	4.547171187966089
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.06727	4.500428547571684
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.067212254	4.496565283904254
XP21 MICRODELETION SYNDROME	0.067212254	4.496565283904254
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067212254	4.496565283904254
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	4.460067189719001
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	4.460067189719001
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06623091	4.430912414087275
X-LINKED ADRENOLEUKODYSTROPHY	0.06605965999999999	4.419455622222079
YUNIS-VARON SYNDROME	0.06414710400000001	4.291503762236507
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.062686764	4.1938055932880784
VON HIPPEL-LINDAU DISEASE	0.06227178	4.166042759329619
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	4.093590342079
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.06115947	4.091628136499986
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.061000374	4.080984459077591
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.06079233	4.067066112760496
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	4.062207094990165
VICI SYNDROME; VICIS	0.060125484	4.022453465588889
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.060125484	4.022453465588889
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.060125484	4.022453465588889
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059891624000000004	4.006808003716805
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.05957993	3.985955371403637
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.05957993	3.985955371403637
15Q OVERGROWTH SYNDROME	0.05952815	3.9824912389494482
BILATERAL POLYMICROGYRIA	0.059369054	3.971847561527054
ALAGILLE SYNDROME 1; ALGS1	0.0591531	3.9574000285024917
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	3.9353494673418017
ATYPICAL WERNER SYNDROME	0.0588235	3.9353494673418017
BUTYRYLCHOLINESTERASE	0.0588235	3.9353494673418017
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	3.9353494673418017
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	3.9353494673418017
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0588235	3.9353494673418017
3M SYNDROME	0.0588235	3.9353494673418017
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	3.9353494673418017
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	3.9353494673418017
ACQUIRED METHEMOGLOBINEMIA	0.0588235	3.9353494673418017
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	3.9353494673418017
TIGLIC ACIDEMIA	0.0588235	3.9353494673418017
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	3.9353494673418017
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	3.9353494673418017
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	3.9353494673418017
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	3.9353494673418017
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	3.9353494673418017
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	3.9353494673418017
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	3.9353494673418017
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0588235	3.9353494673418017
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0588235	3.9353494673418017
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	3.9353494673418017
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	3.9353494673418017
PSEUDOXANTHOMA ELASTICUM	0.0588235	3.9353494673418017
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	3.9353494673418017
MOYAMOYA DISEASE	0.0588235	3.9353494673418017
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.0588235	3.9353494673418017
NOCARDIOSIS	0.0588235	3.9353494673418017
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05863523999999999	3.9227546899021424
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.05824875000000001	3.8968981323081047
JUVENILE POLYPOSIS SYNDROME	0.0579365	3.8760083030531725
H SYNDROME	0.0578571	3.870696365686186
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05776971	3.864849889533781
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	3.835392721497787
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057173184	3.824941718881651
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057173184	3.824941718881651
BÖÖK SYNDROME	0.0566667	3.791057445766023
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0566483	3.78982646783715
HYDROXYKYNURENINURIA	0.056416754	3.774335814819816
RHIZOMELIC SYNDROME, URBACH TYPE	0.056312030000000006	3.7673296771772433
NIJMEGEN BREAKAGE SYNDROME	0.056312030000000006	3.7673296771772433
DISTAL TRISOMY 6P	0.056101154	3.75322186730066
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.055555600000000004	3.716723773115408
BAMFORTH-LAZARUS SYNDROME	0.055555600000000004	3.716723773115408
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	3.716723773115408
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.055555600000000004	3.716723773115408
TRICHO-DENTO-OSSEOUS SYNDROME	0.055555600000000004	3.716723773115408
NOONAN SYNDROME	0.055555600000000004	3.716723773115408
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.055555600000000004	3.716723773115408
ELLIS VAN CREVELD SYNDROME	0.055555600000000004	3.716723773115408
PACHYDERMOPERIOSTOSIS	0.055555600000000004	3.716723773115408
STEINERT MYOTONIC DYSTROPHY	0.055555600000000004	3.716723773115408
ARGININOSUCCINIC ACIDURIA	0.055555600000000004	3.716723773115408
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	3.716723773115408
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05536529999999999	3.7039925176879827
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05520687999999999	3.693394065324279
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.05501935	3.6808481255959293
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.05501935	3.6808481255959293
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.05445044999999999	3.6427881612624438
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.054084214000000005	3.6182866160038087
EMANUEL SYNDROME	0.053933584	3.608209322230645
MECKEL SYNDROME, TYPE 1; MKS1	0.05338803	3.5717112280453924
MEIER-GORLIN SYNDROME 1; MGORS1	0.05338803	3.5717112280453924
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.05313743	3.5549458438619306
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	3.5211053239835572
KNIEST-LIKE DYSPLASIA, LETHAL	0.0526316	3.5211053239835572
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	3.5211053239835572
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	3.5211053239835572
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	3.5211053239835572
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	3.5211053239835572
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	3.5211053239835572
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	3.5211053239835572
CORNELIA DE LANGE SYNDROME 3	0.05245289400000001	3.5091497184532714
PSEUDOXANTHOMA ELASTICUM; PXE	0.0521601	3.4895615145561742
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05190734	3.4726516242680185
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.05138689400000001	3.4378332797478843
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.050907854	3.4057850369735605
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.050362300000000006	3.3692869427883085
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.050310394	3.3658143808113454
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.04996373	3.3426222214235737
AICARDI SYNDROME	0.04983053999999999	3.333711680643864
ERYTHERMALGIA, PRIMARY	0.0494995	3.3115647820800445
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0494129	3.3057711576974116
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.049064484000000005	3.2824617878025
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.048739529999999996	3.26072204856885
AMISH INFANTILE EPILEPSY SYNDROME	0.04763039000000001	3.18651950182805
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.047141	3.1537788339687354
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.047141	3.1537788339687354
MESOMELIA-SYNOSTOSES SYNDROME	0.04689655	3.137424890777804
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04689655	3.137424890777804
WARBURG MICRO SYNDROME 3; WARBM3	0.046572	3.1157121795378107
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.04650225399999999	3.1110461041776354
TRISOMY 20P	0.046419	3.1054763304553297
VICI SYNDROME	0.046000054	3.077448434836317
HAMAMY SYNDROME; HMMS	0.04597704	3.075908775811584
COG1-CDG	0.045956699999999996	3.074548009992383
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04550946	3.0446272182038308
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0454545	3.040950340651065
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	3.040950340651065
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	3.040950340651065
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0454545	3.040950340651065
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	3.040950340651065
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	3.040950340651065
ALAGILLE SYNDROME 2	0.0454545	3.040950340651065
VASCULAR EHLERS-DANLOS SYNDROME	0.044787724	2.996342376547666
SCHWARTZ-JAMPEL SYNDROME	0.04420471	2.957338171861566
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	2.9452387292363302
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.044023854	2.9452387292363302
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814	2.9354903206532934
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	2.908740635051078
KEUTEL SYNDROME; KTLS	0.043478300000000004	2.908740635051078
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	2.908740635051078
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	2.908740635051078
HYDATIDIFORM MOLE	0.043478300000000004	2.908740635051078
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	2.908740635051078
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	2.908740635051078
YELLOW FEVER	0.043478300000000004	2.908740635051078
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	2.908740635051078
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	2.908740635051078
LASSA FEVER	0.043478300000000004	2.908740635051078
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	2.908740635051078
ASHERMAN SYNDROME	0.043478300000000004	2.908740635051078
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	2.908740635051078
49,XXXYY SYNDROME	0.04329801999999999	2.896679727387093
HYDROXYKYNURENINURIA	0.043220353999999996	2.8914837963097075
PIERPONT SYNDROME	0.043192194	2.8895998648707364
LISSENCEPHALY, X-LINKED, 2	0.04312171000000001	2.8848844165914587
PRIMARY HYPEROXALURIA TYPE 1	0.0429832	2.8756179626279654
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.042555699999999995	2.8470177960739753
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042423129999999996	2.838148733898391
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042423129999999996	2.838148733898391
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.042423129999999996	2.838148733898391
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	2.838148733898391
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042423129999999996	2.838148733898391
XP22.13P22.2 DUPLICATION SYNDROME	0.042423129999999996	2.838148733898391
MOWAT-WILSON SYNDROME	0.04238775	2.8357817774242853
NON-DISTAL MONOSOMY 20Q	0.042053259999999995	2.8134040704988017
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.042036014000000003	2.812250296294381
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.04189021	2.802495866623649
HISTIDINEMIA	0.041666699999999994	2.7875428298365557
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	2.7875428298365557
49,XYYYY SYNDROME	0.041666699999999994	2.7875428298365557
PGM3-CDG	0.041666699999999994	2.7875428298365557
ACRORENAL-MANDIBULAR SYNDROME	0.04102532	2.7446338828788996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.04083573	2.7319501271432953
GRISCELLI SYNDROME	0.040545554	2.712537069997165
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.040545554	2.712537069997165
DYSKERATOSIS CONGENITA	0.040545554	2.712537069997165
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.040421939999999996	2.704267172948265
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040421939999999996	2.704267172948265
NEURONAL CEROID LIPOFUSCINOSIS	0.04035632	2.6998771310084457
ACROCEPHALOPOLYDACTYLY	0.04009282	2.682248724255285
SHPRINTZEN OMPHALOCELE SYNDROME	0.04009282	2.682248724255285
FABRY DISEASE	0.04002464000000001	2.6776874158210133
TRIOPIA	0.04	2.676038975811913
MONILETHRIX	0.04	2.676038975811913
ROMBO SYNDROME	0.04	2.676038975811913
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04	2.676038975811913
ACRODERMATITIS ENTEROPATHICA	0.04	2.676038975811913
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	2.676038975811913
SPONDYLO-OCULAR SYNDROME	0.04	2.676038975811913
VOGT-KOYANAGI-HARADA DISEASE	0.04	2.676038975811913
MICROPHTHALMIA WITH LIMB ANOMALIES	0.04	2.676038975811913
ACROMICRIC DYSPLASIA	0.04	2.676038975811913
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.04	2.676038975811913
ULERYTHEMA OPHRYOGENESIS	0.04	2.676038975811913
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	2.676038975811913
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	2.676038975811913
PILI TORTI	0.04	2.676038975811913
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	2.67394497531334
WILLIAMS-BEUREN SYNDROME; WBS	0.03972012	2.657314731098157
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.03916258	2.620014761833803
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.03915465	2.6194842371068483
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.039007054	2.6096099208899997
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.038888900000000004	2.6017053031612978
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.038793140000000004	2.595298865853204
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.038647604	2.58556236564361
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.038476633999999996	2.574124306051245
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	2.5731118267047477
LIP, HAMARTOMATOUS	0.0384615	2.5731118267047477
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	2.5731118267047477
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	2.5731118267047477
BAZEX SYNDROME; BZX	0.0384615	2.5731118267047477
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	2.5731118267047477
JUVENILE MYOCLONIC EPILEPSY	0.0384615	2.5731118267047477
CYCLIC NEUTROPENIA	0.0384615	2.5731118267047477
MAL DE MELEDA	0.0384615	2.5731118267047477
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	2.5731118267047477
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	2.5731118267047477
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	2.5731118267047477
LIP, MEDIAN NODULE OF UPPER	0.0384615	2.5731118267047477
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	2.5731118267047477
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	2.5731118267047477
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	2.5731118267047477
JUVENILE ABSENCE EPILEPSY	0.0384615	2.5731118267047477
ZELLWEGER SYNDROME	0.038102050000000005	2.5490642714583576
OCULOECTODERMAL SYNDROME; OES	0.037891174	2.5349564615817743
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.037760173999999994	2.5261924339359902
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	2.5177807068213722
COFFIN-LOWRY SYNDROME; CLS	0.03742313	2.5036438619219017
OCULODENTODIGITAL DYSPLASIA	0.037337699999999995	2.4979285116793113
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.03732487	2.49707017217782
ATYPICAL RETT SYNDROME	0.037324869999999996	2.49707017217782
PYRIDOXINE-DEPENDENT EPILEPSY	0.036591533999999995	2.44800927921867
HUNTINGTON DISEASE	0.03656844	2.4464642681159847
FLYNN-AIRD SYNDROME	0.03656844	2.4464642681159847
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03647073000000001	2.4399273739078207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03647073000000001	2.4399273739078207
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03647073000000001	2.4399273739078207
MICROHYDRANENCEPHALY; MHAC	0.03647073000000001	2.4399273739078207
THUMBS, CONGENITAL CLASPED	0.0361093	2.4157473547321278
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	2.4115111850334174
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	2.4115111850334174
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.03600232	2.4085902884913186
AICARDI-GOUTIERES SYNDROME 7	0.035915324	2.402770171322825
BRAIN-LUNG-THYROID SYNDROME	0.035784784	2.394036918125263
FAMILIAL CERVICAL ARTERY DISSECTION	0.035714300000000004	2.3893214698459855
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	2.3893214698459855
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.035714300000000004	2.3893214698459855
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	2.3893214698459855
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.035714300000000004	2.3893214698459855
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	2.3893214698459855
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	2.3893214698459855
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	2.3893214698459855
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.035714300000000004	2.3893214698459855
SLC39A8-CDG	0.035714300000000004	2.3893214698459855
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.035714300000000004	2.3893214698459855
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	2.3893214698459855
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	2.3893214698459855
SCHINZEL-GIEDION SYNDROME	0.035714300000000004	2.3893214698459855
SPINOCEREBELLAR ATAXIA TYPE 34	0.035706379999999996	2.388791614128774
WOLF-HIRSCHHORN SYNDROME	0.035191403999999996	2.3543392179385814
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.035191403999999996	2.3543392179385814
JAWAD SYNDROME	0.035028354	2.343431014063428
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.035028354	2.343431014063428
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.035028354	2.343431014063428
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	2.343431014063428
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	2.343431014063428
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.035028354	2.343431014063428
SILVER-RUSSELL SYNDROME	0.0347755	2.3265148350836795
RAMON SYNDROME	0.0345238	2.309675859828383
COCKAYNE SYNDROME A; CSA	0.03450771	2.3085994231503624
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.0344828	2.3069329198781756
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	2.3069329198781756
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	2.3069329198781756
RICHIERI COSTA-DA SILVA SYNDROME	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	2.3069329198781756
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0344828	2.3069329198781756
LENNOX-GASTAUT SYNDROME	0.0344828	2.3069329198781756
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.0344828	2.3069329198781756
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	2.3069329198781756
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	2.3069329198781756
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.0344828	2.3069329198781756
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.0344828	2.3069329198781756
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.0344828	2.3069329198781756
RAMOS-ARROYO SYNDROME	0.0344828	2.3069329198781756
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0344828	2.3069329198781756
GIANT AXONAL NEUROPATHY	0.0344828	2.3069329198781756
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	2.3069329198781756
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.0344828	2.3069329198781756
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	2.3069329198781756
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	2.3069329198781756
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	2.3069329198781756
BECKER MUSCULAR DYSTROPHY	0.0344828	2.3069329198781756
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	2.3069329198781756
FRIEDREICH ATAXIA	0.0344828	2.3069329198781756
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.034296834	2.29449161327378
9P13 MICRODELETION SYNDROME	0.033889419999999996	2.2672352196914938
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	2.2672352196914938
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	2.2672352196914938
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.033751279999999995	2.257993519088527
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033560084	2.245202320388044
SECKEL SYNDROME 2; SCKL2	0.03301453	2.2087042262027916
ISOLATED CEREBELLAR AGENESIS	0.03301453	2.2087042262027916
SECKEL SYNDROME	0.03301453	2.2087042262027916
ISOTRETINOIN-LIKE SYNDROME	0.03301453	2.2087042262027916
MEIER-GORLIN SYNDROME 5; MGORS5	0.03301453	2.2087042262027916
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	2.194596416326209
GRISCELLI SYNDROME TYPE 1	0.032803653999999995	2.194596416326209
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	2.194596416326209
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	2.194596416326209
NETHERTON SYNDROME; NETH	0.032803653999999995	2.194596416326209
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	2.194596416326209
SARCOSINEMIA	0.032803653999999995	2.194596416326209
OXOGLUTARIC ACIDURIA	0.032803653999999995	2.194596416326209
OCULODENTODIGITAL DYSPLASIA; ODDD	0.03269075	2.187043028713082
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.032541504	2.1770583258884817
NEONATAL ADRENOLEUKODYSTROPHY	0.03245483	2.1712597508337437
LEIGH SYNDROME; LS	0.032294224	2.160515052940013
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	2.1580983221409564
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	2.1580983221409564
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	2.1580983221409564
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	2.1580983221409564
DEND SYNDROME	0.0322581	2.1580983221409564
SANDHOFF DISEASE	0.0322581	2.1580983221409564
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	2.1580983221409564
DYSTONIA, JUVENILE-ONSET	0.0322581	2.1580983221409564
THROMBOCYTOPENIA 1	0.0322581	2.1580983221409564
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	2.1580983221409564
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	2.1580983221409564
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	2.1580983221409564
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	2.1580983221409564
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	2.1580983221409564
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	2.1580983221409564
ROWLEY-ROSENBERG SYNDROME	0.0322581	2.1580983221409564
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	2.1580983221409564
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	2.1580983221409564
DIENCEPHALIC SYNDROME	0.0322581	2.1580983221409564
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	2.1580983221409564
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	2.1580983221409564
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	2.1580983221409564
DESMOID TUMOR	0.0322581	2.1580983221409564
LEIGH SYNDROME	0.0322581	2.1580983221409564
MERRF	0.0322581	2.1580983221409564
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	2.1580983221409564
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	2.1580983221409564
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	2.1580983221409564
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	2.1580983221409564
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	2.1580983221409564
MILD CANAVAN DISEASE	0.0322581	2.1580983221409564
LESCH-NYHAN SYNDROME	0.0322581	2.1580983221409564
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	2.1580983221409564
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	2.1580983221409564
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	2.1580983221409564
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	2.1580983221409564
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0322581	2.1580983221409564
DENT DISEASE	0.0322581	2.1580983221409564
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.031604983999999996	2.1144042253477973
AICARDI-GOUTIERES SYNDROME 5	0.031604983999999996	2.1144042253477973
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.031510173999999995	2.108061343965379
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.031059429999999996	2.077906131162545
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.031059429999999996	2.077906131162545
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.031059429999999996	2.077906131162545
FONTAINE PROGEROID SYNDROME; FPS	0.03088642	2.0663315935824147
FOLATE MALABSORPTION, HEREDITARY	0.030848553999999997	2.063798321285962
15Q13.3 MICRODELETION SYNDROME	0.030711104000000003	2.054602782355329
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.030531844000000002	2.0426101136852277
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.030450854000000003	2.0371918037689523
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.030302999999999997	2.0273002271007097
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.030302999999999997	2.0273002271007097
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.030302999999999997	2.0273002271007097
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.030302999999999997	2.0273002271007097
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.030302999999999997	2.0273002271007097
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.030302999999999997	2.0273002271007097
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.030302999999999997	2.0273002271007097
NEONATAL LUPUS ERYTHEMATOSUS	0.030302999999999997	2.0273002271007097
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.030302999999999997	2.0273002271007097
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.030302999999999997	2.0273002271007097
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.030302999999999997	2.0273002271007097
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.030302999999999997	2.0273002271007097
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.030084160000000002	2.0126596178640432
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030080234	2.012396964638567
COFFIN-LOWRY SYNDROME	0.02991014	2.001017510299773
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.029767043999999996	1.9914442484677035
TYSHCHENKO SYNDROME	0.029664304000000002	1.984570842358331
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.029607400000000002	1.9807639093113412
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.02937504	1.9652187989008494
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.02926445	1.9578202201424735
JUVENILE POLYPOSIS OF INFANCY	0.029118750000000002	1.9480727481730786
RAPADILINO SYNDROME	0.029118750000000002	1.9480727481730786
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.9454658848047917
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.029058534	1.9440442390988915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.028900524	1.9334732161346906
DRAVET SYNDROME	0.02870054	1.920094091671221
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.02870054	1.920094091671221
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02853423	1.9089677906195393
MENKES DISEASE	0.02853423	1.9089677906195393
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.9089677906195393
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.028407544	1.9004923737772965
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.8948599807429565
SPINOCEREBELLAR ATAXIA TYPE 5	0.027838480000000002	1.8624214376840107
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.858361886557704
NASAL BONES, ABSENCE OF	0.027777800000000002	1.858361886557704
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.858361886557704
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.858361886557704
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.858361886557704
CLEFT CHIN	0.027777800000000002	1.858361886557704
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.858361886557704
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.858361886557704
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.858361886557704
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.858361886557704
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.858361886557704
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.858361886557704
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.858361886557704
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.858361886557704
OROFACIAL CLEFT 3	0.027777800000000002	1.858361886557704
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.858361886557704
DWARFISM, LEVI TYPE	0.027777800000000002	1.858361886557704
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.858361886557704
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.858361886557704
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.858361886557704
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.858361886557704
DIMPLES, FACIAL	0.027777800000000002	1.858361886557704
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.858361886557704
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.027442104000000002	1.8359034970571002
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.026972464	1.8044841234420925
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.026567074	1.7773631374319827
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.026567074	1.7773631374319827
KOOLEN-DE VRIES SYNDROME; KDVS	0.026496554	1.772645280717626
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.026485324	1.7718939827751672
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.026485324	1.7718939827751672
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.02637839	1.7647399939791804
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.026352160000000003	1.7629851814207917
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.026292354	1.7589841017461065
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.026216034	1.7538782193802571
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02610406	1.7463870496733183
DOWN SYNDROME	0.02605664	1.743214605467493
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.02593977	1.7353958885899148
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.025692184	1.7188321439432805
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025692184	1.7188321439432805
FETAL HYDANTOIN SYNDROME	0.025660604	1.7167194111718769
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.025596743999999998	1.712447114946993
ADDUCTED THUMBS SYNDROME	0.02551008	1.7066492089019991
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.025416349999999997	1.7003785805719276
COG8-CDG	0.025416349999999997	1.7003785805719276
PHELAN-MCDERMID SYNDROME	0.025155504000000002	1.6829277290048121
PITT-HOPKINS SYNDROME	0.02514663	1.6823340497580281
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.024935754	1.6682262398814454
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	1.6682262398814454
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.024935754	1.6682262398814454
SPINOCEREBELLAR ATAXIA 5; SCA5	0.024935754	1.6682262398814454
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.024935754	1.6682262398814454
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.024935754	1.6682262398814454
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.024935754	1.6682262398814454
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.024935754	1.6682262398814454
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.024935754	1.6682262398814454
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.024853824	1.6627450430492388
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.024853824	1.6627450430492388
BARBER-SAY SYNDROME; BBRSAY	0.024753650000000002	1.6560433048401644
MAN1B1-CDG	0.024399074	1.632321824942977
CHROMOSOME 17P13.1 DELETION SYNDROME	0.024399074	1.632321824942977
SPINOCEREBELLAR ATAXIA 26	0.0243902	1.631728145696193
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	1.631728145696193
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0243902	1.631728145696193
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0243902	1.631728145696193
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	1.631728145696193
EPISODIC ATAXIA, TYPE 1; EA1	0.0243902	1.631728145696193
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0243902	1.631728145696193
SPINOCEREBELLAR ATAXIA TYPE 6	0.0243902	1.631728145696193
ADRENOLEUKODYSTROPHY	0.0243902	1.631728145696193
CRANIOFACIOFRONTODIGITAL SYNDROME	0.024358619999999997	1.6296154129247893
MILLER-DIEKER SYNDROME	0.024358619999999997	1.6296154129247893
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.02435661	1.6294809419662553
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	1.6262469488639864
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024029283999999998	1.6075825136213397
POTOCKI-LUPSKI SYNDROME	0.024029283999999998	1.6075825136213397
FOUNTAIN SYNDROME	0.02395686	1.6027372774517348
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.02395686	1.6027372774517348
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.02395686	1.6027372774517348
SCARF SYNDROME	0.02385352	1.5958237307577245
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02378788	1.5914323507984174
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.023753414	1.589126541814909
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.023524184	1.5737908314542748
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.023524184	1.5737908314542748
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.023524184	1.5737908314542748
SILVER-RUSSELL SYNDROME; SRS	0.023272854	1.5569766095595043
KAGAMI-OGATA SYNDROME	0.023272854	1.5569766095595043
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.02308197	1.5442062839630326
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.023010454000000003	1.5394217938781787
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.02297863	1.5372927372690224
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.02297863	1.5372927372690224
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02297863	1.5372927372690224
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.02297863	1.5372927372690224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.02297863	1.5372927372690224
CUTIS LAXA	0.022913954	1.5329658498490322
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.022871094	1.5300984740864498
2Q23.1 MICRODUPLICATION SYNDROME	0.022767754	1.5231849273924398
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.022767754	1.5231849273924398
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.022767754	1.5231849273924398
CHROMOSOME 5Q12 DELETION SYNDROME	0.022767754	1.5231849273924398
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.022767754	1.5231849273924398
FG SYNDROME TYPE 1	0.022767754	1.5231849273924398
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.022767754	1.5231849273924398
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	1.5204785153742522
ATROPHODERMA VERMICULATA; AVA	0.0227273	1.5204785153742522
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	1.5204785153742522
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	1.5204785153742522
AMYLOIDOSIS	0.0227273	1.5204785153742522
COWDEN SYNDROME 5; CWS5	0.0227273	1.5204785153742522
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	1.5204785153742522
LARSEN SYNDROME	0.0227273	1.5204785153742522
COWDEN SYNDROME 6; CWS6	0.0227273	1.5204785153742522
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	1.5204785153742522
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	1.5204785153742522
MUSCULAR HYPERTONIA, LETHAL	0.0227273	1.5204785153742522
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	1.5204785153742522
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	1.5204785153742522
PREPAPILLARY VASCULAR LOOPS	0.0227273	1.5204785153742522
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	1.5204785153742522
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	1.5204785153742522
COCAINE EMBRYOFETOPATHY	0.0227273	1.5204785153742522
RHOMBENCEPHALOSYNAPSIS	0.0227273	1.5204785153742522
THUMB DEFORMITY	0.0227273	1.5204785153742522
SIRENOMELIA	0.0227273	1.5204785153742522
ARTERIES, ANOMALIES OF	0.0227273	1.5204785153742522
CONGENITAL ATRANSFERRINEMIA	0.0227273	1.5204785153742522
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	1.5204785153742522
BETHLEM MYOPATHY 1	0.0227273	1.5204785153742522
WATSON SYNDROME	0.0227273	1.5204785153742522
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	1.5204785153742522
FATCO SYNDROME	0.0227273	1.5204785153742522
NEPHROSIALIDOSIS	0.02265578	1.5156937576855005
SPINAL ARACHNOIDITIS	0.02265578	1.5156937576855005
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	1.5156937576855005
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	1.5156937576855005
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.022525720000000003	1.5069926169556482
RENPENNING SYNDROME 1; RENS1	0.02238775	1.497762289518329
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.02232554	1.4936003799011974
MCDONOUGH SYNDROME	0.02232554	1.4936003799011974
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.022314844	1.4928848070790652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0222222	1.4866868332071874
SMITH-KINGSMORE SYNDROME; SKS	0.0222222	1.4866868332071874
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0222222	1.4866868332071874
ALG13-CDG	0.0222222	1.4866868332071874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0222222	1.4866868332071874
FRONTOMETAPHYSEAL DYSPLASIA	0.0222222	1.4866868332071874
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0222222	1.4866868332071874
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.022195744	1.4849169010285852
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.022195744	1.4849169010285852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.02204304	1.4747008546345257
MENKES DISEASE	0.02201597	1.472889845257645
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.021983694000000005	1.4707305494080627
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.021862439999999997	1.4626185386587347
UNILATERAL POLYMICROGYRIA	0.021862439999999997	1.4626185386587347
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.021850934000000002	1.4618487760473429
KNOBLOCH SYNDROME	0.02163132	1.4471563854564937
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02163132	1.4471563854564937
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02163132	1.4471563854564937
TENORIO SYNDROME; TNORS	0.021305380000000002	1.4253506818620907
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.021106009999999998	1.4120126345968997
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.021106009999999998	1.4120126345968997
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.021106009999999998	1.4120126345968997
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.021106009999999998	1.4120126345968997
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	1.4068793228315488
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	1.4068793228315488
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	1.4068793228315488
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	1.4068793228315488
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	1.4068793228315488
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.020943034000000003	1.401109381393852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.020790404	1.3908982856718974
NEVUS COMEDONICUS SYNDROME	0.02075643	1.3886253919677916
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02075643	1.3886253919677916
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02075642	1.3886247229580477
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.020740849999999998	1.3875830747867128
CONGENITAL HYPOTHYROIDISM	0.020545554	1.3745175820912088
MEGAEPIPHYSEAL DWARFISM	0.02049922	1.371417792343577
WILLIAMS SYNDROME	0.02039669	1.3645584354388272
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.020392254000000002	1.36426166271641
HYPERMANGANESEMIA WITH DYSTONIA 2	0.020352374000000003	1.3615936518575253
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020169884	1.3493848930401273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.020033974	1.3402923816100623
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020033974	1.3402923816100623
WEBB-DATTANI SYNDROME; WEDAS	0.020001164000000002	1.3380973606401527
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.020001164000000002	1.3380973606401527
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	1.3380194879059566
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	1.3380194879059566
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	1.3380194879059566
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	1.3380194879059566
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	1.3380194879059566
RINGED HAIR	0.02	1.3380194879059566
DARIER DISEASE	0.02	1.3380194879059566
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	1.3380194879059566
MIDPHALANGEAL HAIR	0.02	1.3380194879059566
TRICHODENTOOSSEOUS SYNDROME	0.02	1.3380194879059566
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	1.3380194879059566
HAIR WHORL	0.02	1.3380194879059566
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	1.3380194879059566
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	1.3380194879059566
FAMILIAL MELANOMA	0.02	1.3380194879059566
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	1.3380194879059566
DISSECTING CELLULITIS OF THE SCALP	0.02	1.3380194879059566
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	1.3380194879059566
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	1.3380194879059566
VAN BOGAERT-HOZAY SYNDROME	0.02	1.3380194879059566
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	1.3380194879059566
GYRATE ATROPHY OF CHOROID AND RETINA	0.02	1.3380194879059566
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	1.3380194879059566
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	1.3380194879059566
HAIRY NOSE TIP	0.02	1.3380194879059566
611426 TENTED EYEBROWS	0.02	1.3380194879059566
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	1.3380194879059566
INHERITED EPIDERMOLYSIS BULLOSA	0.02	1.3380194879059566
CATATRICHY	0.02	1.3380194879059566
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	1.3380194879059566
WERNER SYNDROME; WRN	0.02	1.3380194879059566
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	1.3380194879059566
STRIATE PALMOPLANTAR KERATODERMA	0.02	1.3380194879059566
PEHO SYNDROME	0.019882504	1.3301588910184066
8P INVERTED DUPLICATION/DELETION SYNDROME	0.0196803	1.31663124639178
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.019636004000000002	1.3136678008299658
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.019620494	1.3126301667170945
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.019600004	1.311259365751735
DOORS SYNDROME	0.019600004	1.311259365751735
TRISOMY 18	0.019600004	1.311259365751735
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01950752	1.3050720960357602
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01950752	1.3050720960357602
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.019503894	1.304829513102603
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.019503894	1.304829513102603
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.01948842	1.3037942874248099
CHROMOSOME 17Q12 DELETION SYNDROME	0.01948842	1.3037942874248099
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.01948842	1.3037942874248099
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.01945561	1.3015992664549005
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01945561	1.3015992664549005
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01945561	1.3015992664549005
WARBURG MICRO SYNDROME 2; WARBM2	0.01945561	1.3015992664549005
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.019443074	1.300760595839881
BAND HETEROTOPIA; BH	0.019413454	1.2987789889782921
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	1.2987789889782921
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.01933695	1.2936607968331542
SECKEL SYNDROME 9; SCKL9	0.019159084	1.2817613881213603
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019159084	1.2817613881213603
COFFIN-SIRIS SYNDROME 4; CSS4	0.019159084	1.2817613881213603
COFFIN-SIRIS SYNDROME 3; CSS3	0.019159084	1.2817613881213603
JACOBSEN SYNDROME	0.019126074	1.2795529869565714
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01905445	1.2747612715664827
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.01889752	1.2642625016546287
VAN DEN BOSCH SYNDROME	0.0188679	1.2622808947930397
PACHYDERMODACTYLY, FAMILIAL	0.0188679	1.2622808947930397
KNUCKLE PADS	0.0188679	1.2622808947930397
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	1.2622808947930397
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	1.2622808947930397
VESICOURETERAL REFLUX 1	0.0188679	1.2622808947930397
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	1.2622808947930397
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	1.2622808947930397
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	1.2622808947930397
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	1.2622808947930397
LETTERER-SIWE DISEASE	0.0188679	1.2622808947930397
HHHH SYNDROME	0.0188679	1.2622808947930397
RAYNAUD DISEASE	0.0188679	1.2622808947930397
CARPAL DISPLACEMENT	0.0188679	1.2622808947930397
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	1.2622808947930397
MONOPHALANGY OF GREAT TOE	0.0188679	1.2622808947930397
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	1.2622808947930397
TRACHEOBRONCHOMEGALY	0.0188679	1.2622808947930397
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	1.2622808947930397
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	1.2622808947930397
DOUBLE NAIL FOR FIFTH TOE	0.0188679	1.2622808947930397
THROMBOCYTOPENIA 3	0.0188679	1.2622808947930397
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	1.2622808947930397
THALIDOMIDE SUSCEPTIBILITY	0.0188679	1.2622808947930397
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	1.2622808947930397
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	1.2622808947930397
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	1.2622808947930397
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	1.2622808947930397
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	1.2622808947930397
TOE, MISSHAPEN	0.0188679	1.2622808947930397
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	1.2622808947930397
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	1.2622808947930397
PUBIC BONE DYSPLASIA	0.0188679	1.2622808947930397
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	1.2622808947930397
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	1.2622808947930397
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	1.2622808947930397
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	1.2622808947930397
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	1.2622808947930397
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018843574	1.2606534616899
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.018760934	1.2551247651658726
FUMARASE DEFICIENCY; FMRD	0.018760934	1.2551247651658726
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.018747464	1.2542236090407677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018747464	1.2542236090407677
BLOOM SYNDROME	0.01861353	1.245263293936108
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01861353	1.245263293936108
FILIPPI SYNDROME; FLPIS	0.01861353	1.245263293936108
AMISH LETHAL MICROCEPHALY	0.01858054	1.243056230790807
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01858052	1.243054892771319
WHITE FORELOCK WITH MALFORMATIONS	0.01858052	1.243054892771319
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.01858052	1.243054892771319
RING CHROMOSOME 8 SYNDROME	0.01858052	1.243054892771319
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01858052	1.243054892771319
CARTILAGE-HAIR HYPOPLASIA	0.01858052	1.243054892771319
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.01858052	1.243054892771319
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.01858052	1.243054892771319
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.018580094000000002	1.2430263929562269
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.018568004000000003	1.2422175601757879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.018554493999999998	1.241313728011707
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.018554493999999998	1.241313728011707
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.018554493999999998	1.241313728011707
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.018402654	1.2311554840595251
SRD5A3-CDG	0.018402654	1.2311554840595251
COFFIN-SIRIS SYNDROME 2; CSS2	0.018402654	1.2311554840595251
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.018402654	1.2311554840595251
SAETHRE-CHOTZEN SYNDROME	0.018298019999999998	1.2241553675046475
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.018298019999999998	1.2241553675046475
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.018298019999999998	1.2241553675046475
COSTELLO SYNDROME	0.018298019999999998	1.2241553675046475
CEREBROOCULONASAL SYNDROME	0.018298019999999998	1.2241553675046475
NASODIGITOACOUSTIC SYNDROME	0.018298019999999998	1.2241553675046475
PITT-HOPKINS SYNDROME	0.018251184	1.2210219934678694
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.01820191	1.2177255148555155
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.018175320000000002	1.2159466179463447
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.018022450000000002	1.2057194659905355
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.018022450000000002	1.2057194659905355
RETT SYNDROME, CONGENITAL VARIANT	0.018008939999999998	1.2048156338264548
PROPIONIC ACIDEMIA	0.018004504	1.2045188611040374
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.018004504	1.2045188611040374
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017970094000000002	1.2022167985750953
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.017968684	1.2021224682011977
BOHRING-OPITZ SYNDROME	0.017968684	1.2021224682011977
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017968684	1.2021224682011977
PAPILLON-LEFÈVRE SYNDROME	0.0178571	1.1946573898742727
ADRENOCORTICAL CARCINOMA	0.0178571	1.1946573898742727
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.0178571	1.1946573898742727
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.0178571	1.1946573898742727
TUFTED ANGIOMA	0.0178571	1.1946573898742727
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.0178571	1.1946573898742727
POEMS SYNDROME	0.0178571	1.1946573898742727
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0178571	1.1946573898742727
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0178571	1.1946573898742727
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0178571	1.1946573898742727
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0178571	1.1946573898742727
PORPHYRIA CUTANEA TARDA, TYPE I	0.0178571	1.1946573898742727
ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 2; EKVP2	0.0178571	1.1946573898742727
KASABACH-MERRITT SYNDROME	0.0178571	1.1946573898742727
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0178571	1.1946573898742727
144800 HYPEROSTOSIS FRONTALIS INTERNA;;MORGAGNI-STEWART-MOREL SYNDROME	0.0178571	1.1946573898742727
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0178571	1.1946573898742727
HEREDITARY COPROPORPHYRIA	0.0178571	1.1946573898742727
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0178571	1.1946573898742727
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0178571	1.1946573898742727
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.017811574	1.1916116561139525
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01770563	1.184523899282617
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.01770563	1.184523899282617
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.01770563	1.184523899282617
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.01770563	1.184523899282617
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01770563	1.184523899282617
DYSOSTOSIS, STANESCU TYPE	0.01770563	1.184523899282617
TRISOMY 4P	0.01770563	1.184523899282617
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.01770563	1.184523899282617
COCKAYNE SYNDROME	0.01770563	1.184523899282617
TEMTAMY SYNDROME	0.017494754	1.1704160894060343
COLCHICINE POISONING	0.01745895	1.168020766918785
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.01745895	1.168020766918785
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.01745895	1.168020766918785
PEARSON SYNDROME	0.01745895	1.168020766918785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.017424540000000002	1.165718704389843
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.01742313	1.1656243740159453
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.01726602	1.1551135619287003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.01726602	1.1551135619287003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01726602	1.1551135619287003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	1.1551135619287003
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01726602	1.1551135619287003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	1.1551135619287003
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.1534664599390878
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.1534664599390878
CARDIAC ARRHYTHMIA	0.0172414	1.1534664599390878
MOSAIC TRISOMY 15	0.0172414	1.1534664599390878
MYOPATHY, CONGENITAL	0.0172414	1.1534664599390878
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.1534664599390878
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.1534664599390878
CERVICAL RIB	0.0172414	1.1534664599390878
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.1534664599390878
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.1534664599390878
PALMOMENTAL REFLEX	0.0172414	1.1534664599390878
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.1534664599390878
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.1534664599390878
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.1534664599390878
RHEUMATOID ARTHRITIS	0.0172414	1.1534664599390878
JUMPING FRENCHMAN OF MAINE	0.0172414	1.1534664599390878
SICKLE CELL ANEMIA	0.0172414	1.1534664599390878
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.1534664599390878
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.1534664599390878
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.1534664599390878
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.1534664599390878
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.1534664599390878
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.1534664599390878
MOTION SICKNESS	0.0172414	1.1534664599390878
TRANSSEXUALITY	0.0172414	1.1534664599390878
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.1534664599390878
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.1534664599390878
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.1534664599390878
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.1534664599390878
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.1534664599390878
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.1534664599390878
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.1534664599390878
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.1534664599390878
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.1534664599390878
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.1534664599390878
269800 SENILE PLAQUE FORMATION	0.0172414	1.1534664599390878
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.1534664599390878
DIASTEMATOMYELIA	0.0172414	1.1534664599390878
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.1534664599390878
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.1534664599390878
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.1534664599390878
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.1534664599390878
ALCOHOL DEPENDENCE	0.0172414	1.1534664599390878
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.017212254	1.1515165641393628
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.017212254	1.1515165641393628
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.017212254	1.1515165641393628
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.017212254	1.1515165641393628
ALPHA-MANNOSIDOSIS	0.017212254	1.1515165641393628
ABETA AMYLOIDOSIS, IOWA TYPE	0.01714688	1.1471429798392445
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01714688	1.1471429798392445
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.01696854	1.135211860065587
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.01696854	1.135211860065587
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.0169492	1.1339179952207818
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.0169492	1.1339179952207818
DEAFNESS-CRANIOFACIAL SYNDROME	0.0169492	1.1339179952207818
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.0169492	1.1339179952207818
MUCKLE-WELLS SYNDROME	0.0169492	1.1339179952207818
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0169492	1.1339179952207818
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0169492	1.1339179952207818
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0169492	1.1339179952207818
FAMILIAL TUMORAL CALCINOSIS	0.0169492	1.1339179952207818
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0169492	1.1339179952207818
GAMMA-HEAVY CHAIN DISEASE	0.0169492	1.1339179952207818
JACKSON-WEISS SYNDROME	0.0169492	1.1339179952207818
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0169492	1.1339179952207818
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0169492	1.1339179952207818
HEART-HAND SYNDROME TYPE 2	0.0169492	1.1339179952207818
MCCUNE-ALBRIGHT SYNDROME	0.0169492	1.1339179952207818
GRANT SYNDROME	0.0169492	1.1339179952207818
ENDOCARDIAL FIBROELASTOSIS	0.0169492	1.1339179952207818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.016904094	1.1309003598697078
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.016904094	1.1309003598697078
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.016904094	1.1309003598697078
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.016904094	1.1309003598697078
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.016904094	1.1309003598697078
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.016691710000000002	1.1166916633237367
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0166667	1.1150184699541104
MARFAN SYNDROME; MFS	0.0166667	1.1150184699541104
PYCNODYSOSTOSIS	0.0166667	1.1150184699541104
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0166667	1.1150184699541104
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0166667	1.1150184699541104
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0166667	1.1150184699541104
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0166667	1.1150184699541104
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0166667	1.1150184699541104
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0166667	1.1150184699541104
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0166667	1.1150184699541104
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0166667	1.1150184699541104
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.0166667	1.1150184699541104
PYCNODYSOSTOSIS	0.0166667	1.1150184699541104
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0166667	1.1150184699541104
RAMON SYNDROME	0.0166667	1.1150184699541104
APERT SYNDROME	0.0166667	1.1150184699541104
CROUZON DISEASE	0.0166667	1.1150184699541104
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.016631904	1.1126905836490515
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.016631904	1.1126905836490515
RETT SYNDROME; RTT	0.01635854	1.0944022656844554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01635854	1.0944022656844554
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01635854	1.0944022656844554
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.016106480000000003	1.0775392060783766
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.016106480000000003	1.0775392060783766
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.015875473999999997	1.062084679587216
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.015875473999999997	1.062084679587216
PEHO SYNDROME; PEHO	0.015875473999999997	1.062084679587216
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.015875473999999997	1.062084679587216
PEHO-LIKE SYNDROME; PEHOL	0.015875473999999997	1.062084679587216
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.015558713999999998	1.0408931269377617
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.015346424000000001	1.026690719083384
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.015272594	1.0217514201437792
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.015193554	1.0164635671275748
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.015193554	1.0164635671275748
LOWRY-MACLEAN SYNDROME	0.01506039	1.0075547657731994
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.015000583999999997	1.003553686098514
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.015000583999999997	1.003553686098514
CEDNIK SYNDROME	0.015000583999999997	1.003553686098514
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.014981504000000003	1.002277215507052
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.01472704	0.9852533259585269
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.014648	0.9799654729423225
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.014437123999999999	0.9658576630657396
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.014437123999999999	0.9658576630657396
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014437123999999999	0.9658576630657396
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.014437123999999999	0.9658576630657396
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014437123999999999	0.9658576630657396
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014437123999999999	0.9658576630657396
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.014437123999999999	0.9658576630657396
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.014437123999999999	0.9658576630657396
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.014437123999999999	0.9658576630657396
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01441507	0.9643822289764259
QAZI-MARKOUIZOS SYNDROME	0.014303960000000001	0.9569488617113644
TRISOMY 13	0.014303960000000001	0.9569488617113644
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014244153999999998	0.952947782036679
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014244153999999998	0.952947782036679
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014244153999999998	0.952947782036679
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014244153999999998	0.952947782036679
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.014244153999999998	0.952947782036679
ABETAL34V AMYLOIDOSIS	0.014244153999999998	0.952947782036679
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.952947782036679
CITRULLINEMIA, CLASSIC	0.014244153999999998	0.952947782036679
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014244153999999998	0.952947782036679
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014244153999999998	0.952947782036679
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014244153999999998	0.952947782036679
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.014244153999999998	0.952947782036679
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.014244153999999998	0.952947782036679
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014244153999999998	0.952947782036679
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.014244153999999998	0.952947782036679
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014244153999999998	0.952947782036679
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.014244153999999998	0.952947782036679
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.014244153999999998	0.952947782036679
MEIER-GORLIN SYNDROME 7	0.014244153999999998	0.952947782036679
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.014244153999999998	0.952947782036679
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014244153999999998	0.952947782036679
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014244153999999998	0.952947782036679
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014244153999999998	0.952947782036679
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.014244153999999998	0.952947782036679
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014244153999999998	0.952947782036679
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.014244153999999998	0.952947782036679
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014244153999999998	0.952947782036679
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.014244153999999998	0.952947782036679
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014244153999999998	0.952947782036679
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.014225074000000002	0.951671311445217
8Q24.3 MICRODELETION SYNDROME	0.014225074	0.951671311445217
WITTEVEEN-KOLK SYNDROME	0.014140194	0.9459927567385439
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.013960184	0.9339499123376465
LIVER FAILURE, INFANTILE, TRANSIENT	0.013891569999999999	0.9293595688804874
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.013891569999999999	0.9293595688804874
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.013891569999999999	0.9293595688804874
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	0.9293595688804874
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	0.9293595688804874
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.013891569999999999	0.9293595688804874
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	0.9293595688804874
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	0.9293595688804874
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.013698599999999998	0.9164496878514268
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	0.9164496878514268
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.013698599999999998	0.9164496878514268
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	0.9164496878514268
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	0.9164496878514268
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	0.9164496878514268
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013698599999999998	0.9164496878514268
POLYCYTHEMIA VERA	0.013698599999999998	0.9164496878514268
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	0.9164496878514268
PRADER-WILLI SYNDROME	0.013698599999999998	0.9164496878514268
SNEDDON SYNDROME	0.013698599999999998	0.9164496878514268
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	0.9164496878514268
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	0.9164496878514268
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	0.9164496878514268
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	0.9164496878514268
AMYLOIDOSIS VI	0.013698599999999998	0.9164496878514268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.013698599999999998	0.9164496878514268
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.9164496878514268
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	0.9164496878514268
SECONDARY POLYCYTHEMIA	0.013698599999999998	0.9164496878514268
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	0.9164496878514268
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.013698599999999998	0.9164496878514268
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.013698599999999998	0.9164496878514268
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	0.9164496878514268
FAMILIAL AORTIC DISSECTION	0.013698599999999998	0.9164496878514268
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.013698599999999998	0.9164496878514268
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.013698599999999998	0.9164496878514268
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	0.9164496878514268
STURGE-WEBER SYNDROME	0.013698599999999998	0.9164496878514268
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	0.9164496878514268
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	0.9164496878514268
STROKE, ISCHEMIC	0.013698599999999998	0.9164496878514268
AORTA COARCTATION	0.013698599999999998	0.9164496878514268
SICKLE CELL ANEMIA	0.013698599999999998	0.9164496878514268
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.013698599999999998	0.9164496878514268
EISENMENGER SYNDROME	0.013698599999999998	0.9164496878514268
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013698599999999998	0.9164496878514268
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.013698599999999998	0.9164496878514268
WALDENSTRÖM MACROGLOBULINEMIA	0.013698599999999998	0.9164496878514268
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	0.9164496878514268
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	0.9164496878514268
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	0.9164496878514268
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	0.9164496878514268
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	0.9164496878514268
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.013698599999999998	0.9164496878514268
ABETA AMYLOIDOSIS, DUTCH TYPE	0.013698599999999998	0.9164496878514268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.013698599999999998	0.9164496878514268
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	0.9164496878514268
ACYS AMYLOIDOSIS	0.013698599999999998	0.9164496878514268
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.013698599999999998	0.9164496878514268
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.013679520000000002	0.9151732172599647
PALLISTER-KILLIAN SYNDROME	0.013679520000000002	0.9151732172599647
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.013574874	0.9081722978933943
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01354018	0.9058512354877238
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.013414630000000002	0.8974518181523943
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.013414630000000002	0.8974518181523943
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.013414630000000002	0.8974518181523943
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.013350184000000003	0.8931403179565148
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.013350004000000002	0.8931282757811237
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.013203754000000002	0.8833440082758114
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.013203754000000002	0.8833440082758114
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.013203754000000002	0.8833440082758114
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.013203754000000002	0.8833440082758114
CORNELIA DE LANGE SYNDROME 1	0.01302932	0.8716742037081419
4Q21 MICRODELETION SYNDROME	0.01278375	0.8552453314258887
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.012658200000000001	0.8468459140905591
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.012658200000000001	0.8468459140905591
SPINOCEREBELLAR ATAXIA 37; SCA37	0.012658200000000001	0.8468459140905591
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.012658200000000001	0.8468459140905591
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.012658200000000001	0.8468459140905591
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.012658200000000001	0.8468459140905591
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	0.8468459140905591
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.012658200000000001	0.8468459140905591
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.012658200000000001	0.8468459140905591
MYOPATHY AND DIABETES MELLITUS	0.012658200000000001	0.8468459140905591
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.012658200000000001	0.8468459140905591
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.012658200000000001	0.8468459140905591
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.012658200000000001	0.8468459140905591
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	0.8468459140905591
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	0.8468459140905591
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.012658200000000001	0.8468459140905591
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.012658200000000001	0.8468459140905591
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.012658200000000001	0.8468459140905591
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.012658200000000001	0.8468459140905591
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012658200000000001	0.8468459140905591
PURE MITOCHONDRIAL MYOPATHY	0.012658200000000001	0.8468459140905591
MULTIPLE SYSTEM ATROPHY	0.012658200000000001	0.8468459140905591
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.012658200000000001	0.8468459140905591
CAP MYOPATHY	0.012658200000000001	0.8468459140905591
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.012658200000000001	0.8468459140905591
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.012658200000000001	0.8468459140905591
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.012658200000000001	0.8468459140905591
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.012658200000000001	0.8468459140905591
SPINOCEREBELLAR ATAXIA 44; SCA44	0.012658200000000001	0.8468459140905591
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.012658200000000001	0.8468459140905591
X-LINKED DYSTONIA-PARKINSONISM	0.012658200000000001	0.8468459140905591
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.012658200000000001	0.8468459140905591
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.012658200000000001	0.8468459140905591
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.012658200000000001	0.8468459140905591
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.012658200000000001	0.8468459140905591
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.012658200000000001	0.8468459140905591
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.012658200000000001	0.8468459140905591
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.012658200000000001	0.8468459140905591
STIFF-PERSON SYNDROME; SPS	0.012658200000000001	0.8468459140905591
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.012658200000000001	0.8468459140905591
HYPEREKPLEXIA 1; HKPX1	0.012658200000000001	0.8468459140905591
NEMALINE MYOPATHY 3; NEM3	0.012658200000000001	0.8468459140905591
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.012658200000000001	0.8468459140905591
NEMALINE MYOPATHY 2; NEM2	0.012658200000000001	0.8468459140905591
PRIMARY PROGRESSIVE FREEZING GAIT	0.012658200000000001	0.8468459140905591
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.012658200000000001	0.8468459140905591
EPISODIC ATAXIA TYPE 4	0.012658200000000001	0.8468459140905591
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.012658200000000001	0.8468459140905591
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.012654574	0.8466033311574016
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.012593754000000002	0.8425344138946798
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.012593754000000002	0.8425344138946798
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.012593754000000002	0.8425344138946798
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.012593754000000002	0.8425344138946798
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.012593754000000002	0.8425344138946798
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.012593754000000002	0.8425344138946798
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012593754000000002	0.8425344138946798
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.012593754000000002	0.8425344138946798
RECOMBINANT CHROMOSOME 8 SYNDROME	0.012593754000000002	0.8425344138946798
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.012593754000000002	0.8425344138946798
MENTAL RETARDATION, X-LINKED 98; MRX98	0.012593754000000002	0.8425344138946798
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.012593754000000002	0.8425344138946798
COG2-CDG	0.012593754000000002	0.8425344138946798
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.012593754000000002	0.8425344138946798
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012593754000000002	0.8425344138946798
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.012593754000000002	0.8425344138946798
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.012593754000000002	0.8425344138946798
LISSENCEPHALY 1; LIS1	0.012593754000000002	0.8425344138946798
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.012593754000000002	0.8425344138946798
ANGELMAN SYNDROME	0.012593754000000002	0.8425344138946798
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.012593754000000002	0.8425344138946798
TRISOMY XQ28	0.01248701	0.8353931362838278
CHRISTIANSON SYNDROME	0.012474180000000001	0.8345347967823362
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.012474180000000001	0.8345347967823362
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.012474180000000001	0.8345347967823362
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.012461644000000001	0.8336961261673168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012461644000000001	0.8336961261673168
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012461644000000001	0.8336961261673168
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.01210902	0.8101052369721492
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012048200000000002	0.8060363197094275
MENTAL RETARDATION, X-LINKED 1	0.012048200000000002	0.8060363197094275
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.8060363197094275
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.012048200000000002	0.8060363197094275
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.8060363197094275
BARAITSER-WINTER SYNDROME 2; BRWS2	0.012048200000000002	0.8060363197094275
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01195172	0.7995817136997689
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011951719999999999	0.7995817136997688
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.011898144	0.7959974270955664
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.011757924	0.7866165724658578
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.011718684000000002	0.7839913782305865
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.011718684	0.7839913782305863
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.011717749999999999	0.783928892720501
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.011705214	0.7830902221054816
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.011705214	0.7830902221054816
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.011705214	0.7830902221054816
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.01161212	0.7768621427951258
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.01135259	0.7594993329103141
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.011229984	0.7512968720436043
KLEEFSTRA SYNDROME	0.010988664	0.735152328902531
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010962254000000001	0.7333854741687512
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010962254000000001	0.7333854741687512
MICROVILLUS INCLUSION DISEASE	0.010962254000000001	0.7333854741687512
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010962254000000001	0.7333854741687512
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010962254000000001	0.7333854741687512
ISOVALERIC ACIDEMIA	0.010962254000000001	0.7333854741687512
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.010962254000000001	0.7333854741687512
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.010962254000000001	0.7333854741687512
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010962254000000001	0.7333854741687512
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010962254000000001	0.7333854741687512
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.010843154	0.7254175681182713
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01068443	0.714798777858352
GAPO SYNDROME; GAPOS	0.01068443	0.714798777858352
NON-DISTAL MONOSOMY 10Q	0.01045594	0.6995125742187704
GLUTARIC ACIDEMIA I; GA1	0.010416700000000001	0.6968873799834989
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	0.6968873799834989
HEREDITARY FRUCTOSE INTOLERANCE	0.010416700000000001	0.6968873799834989
PRIMARY HYPEROXALURIA	0.010416700000000001	0.6968873799834989
NEUROLEPTIC MALIGNANT SYNDROME	0.010416700000000001	0.6968873799834989
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	0.6968873799834989
RIBOFLAVIN DEFICIENCY	0.010416700000000001	0.6968873799834989
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	0.6968873799834989
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.010416700000000001	0.6968873799834989
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	0.6968873799834989
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.010416700000000001	0.6968873799834989
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	0.6968873799834989
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	0.6968873799834989
HAWKINSINURIA	0.010416700000000001	0.6968873799834989
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	0.6968873799834989
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010416700000000001	0.6968873799834989
HAWKINSINURIA	0.010416700000000001	0.6968873799834989
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	0.6968873799834989
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	0.6968873799834989
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.010344830000000001	0.692079206953709
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.010344830000000001	0.692079206953709
SMITH-MAGENIS SYNDROME	0.010126604	0.6774796749153206
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009829854	0.657626810763516
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.009829854	0.657626810763516
KOOLEN-DE VRIES SYNDROME	0.009829854	0.657626810763516
HALL-RIGGS SYNDROME	0.00979516	0.6553057483578455
RING CHROMOSOME 7 SYNDROME	0.00979516	0.6553057483578455
TEMPLE-BARAITSER SYNDROME	0.00979516	0.6553057483578455
MONOSOMY 5P	0.00979516	0.6553057483578455
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00968668	0.6480483306554435
ACROOTOOCULAR SYNDROME	0.0092843	0.6211287165782636
RENPENNING SYNDROME	0.0092843	0.6211287165782636
MARDEN-WALKER SYNDROME	0.0092843	0.6211287165782636
EPILEPSY-TELANGIECTASIA	0.00916422	0.6130952475728763
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.009073424	0.6070209067016807
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.009073424	0.6070209067016807
11Q22.2Q22.3 MICRODELETION SYNDROME	0.009073424	0.6070209067016807
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.009073424	0.6070209067016807
LATERAL MENINGOCELE SYNDROME	0.009073424	0.6070209067016807
SIALURIA	0.009073424	0.6070209067016807
COFFIN-SIRIS SYNDROME 6; CSS6	0.009073424	0.6070209067016807
SIMPSON-GOLABI-BEHMEL SYNDROME	0.009073424	0.6070209067016807
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.009073424	0.6070209067016807
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.009073424	0.6070209067016807
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.009073424	0.6070209067016807
DISTAL MONOSOMY 9P	0.009073424	0.6070209067016807
PERLMAN SYNDROME	0.009073424	0.6070209067016807
CHROMOSOME 9P DELETION SYNDROME	0.009073424	0.6070209067016807
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.6046998442960103
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00903873	0.6046998442960103
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.6046998442960103
ASPARTYLGLUCOSAMINURIA; AGU	0.00885465	0.5923847129293239
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00882462	0.5903756766682331
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00882462	0.5903756766682331
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008709393999999999	0.5826669449925604
ADENYLOSUCCINASE DEFICIENCY	0.008709393999999999	0.5826669449925604
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008709393999999999	0.5826669449925604
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.008643774	0.578276903052741
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008538144000000001	0.5712101531273659
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00852787	0.5705228125164284
LEGIUS SYNDROME	0.00852787	0.5705228125164284
VELO-FACIAL-SKELETAL SYNDROME	0.00852787	0.5705228125164284
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00852787	0.5705228125164284
TURNER SYNDROME	0.00852787	0.5705228125164284
CLASSICAL EHLERS-DANLOS SYNDROME	0.00852787	0.5705228125164284
3P25.3 MICRODELETION SYNDROME	0.00852787	0.5705228125164284
MONOSOMY X	0.00852787	0.5705228125164284
CRANIOECTODERMAL DYSPLASIA 1	0.00852787	0.5705228125164284
MOSAIC MONOSOMY X	0.00852787	0.5705228125164284
600736 VELOFACIOSKELETAL SYNDROME	0.00852787	0.5705228125164284
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00852787	0.5705228125164284
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00852787	0.5705228125164284
16P12.1P12.3 TRIPLICATION SYNDROME	0.00852787	0.5705228125164284
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00851505	0.5696651420246808
PELIZAEUS-MERZBACHER DISEASE	0.00851505	0.5696651420246808
ISOLATED COMPLEX I DEFICIENCY	0.008344233999999999	0.5582373851823734
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.008344233999999999	0.5582373851823734
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.008344233999999999	0.5582373851823734
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.008344233999999999	0.5582373851823734
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.008344233999999999	0.5582373851823734
INFANTILE LIVER FAILURE SYNDROME 1	0.008344233999999999	0.5582373851823734
HOLOPROSENCEPHALY	0.008309644000000001	0.5559232804780403
CHROMOSOME 1P36 DELETION SYNDROME	0.008309644000000001	0.5559232804780403
19P13.12 MICRODELETION SYNDROME	0.008309644	0.5559232804780402
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.008309644	0.5559232804780402
DESBUQUOIS DYSPLASIA 2; DBQD2	0.008309644	0.5559232804780402
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.008309644	0.5559232804780402
17Q21.31 MICRODUPLICATION SYNDROME	0.008309644	0.5559232804780402
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008309644	0.5559232804780402
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008309644	0.5559232804780402
1Q44 MICRODELETION SYNDROME	0.008309644	0.5559232804780402
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008309644	0.5559232804780402
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.008309644	0.5559232804780402
FETAL TRIMETHADIONE SYNDROME	0.008309644	0.5559232804780402
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.008309644	0.5559232804780402
MONOSOMY 9P	0.008309644	0.5559232804780402
BARATELA-SCOTT SYNDROME	0.008309644	0.5559232804780402
2Q31.1 MICRODELETION SYNDROME	0.008309644	0.5559232804780402
NIEMANN-PICK DISEASE TYPE C	0.008304174000000001	0.555557332148098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.008304174000000001	0.555557332148098
OCULO-PALATO-CEREBRAL SYNDROME	0.008198534	0.5484899132129787
OROFACIODIGITAL SYNDROME TYPE 4	0.008198534	0.5484899132129787
DISTAL MONOSOMY 12Q	0.008198534	0.5484899132129787
COHEN SYNDROME	0.008198534	0.5484899132129787
RING CHROMOSOME 12 SYNDROME	0.008198534	0.5484899132129787
EAR-PATELLA-SHORT STATURE SYNDROME	0.008198534	0.5484899132129787
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.008198534	0.5484899132129787
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008198534	0.5484899132129787
HEART AND BRAIN MALFORMATION SYNDROME	0.008198534	0.5484899132129787
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00816384	0.5461688508073081
DISTAL MONOSOMY 10P	0.00816384	0.5461688508073081
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00816384	0.5461688508073081
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00816384	0.5461688508073081
DPM1-CDG	0.00816384	0.5461688508073081
YUNIS-VARON SYNDROME	0.00816384	0.5461688508073081
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00816384	0.5461688508073081
COFS SYNDROME	0.00816384	0.5461688508073081
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.5461688508073081
SECKEL SYNDROME 7; SCKL7	0.00816384	0.5461688508073081
ALLAN-HERNDON-DUDLEY SYNDROME	0.00816384	0.5461688508073081
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.5461688508073081
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00816384	0.5461688508073081
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00816384	0.5461688508073081
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00816384	0.5461688508073081
HENNEKAM-BEEMER SYNDROME	0.00816384	0.5461688508073081
BOWEN-CONRADI SYNDROME	0.00816384	0.5461688508073081
CROME SYNDROME	0.00816384	0.5461688508073081
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00816384	0.5461688508073081
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00816384	0.5461688508073081
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00816384	0.5461688508073081
KEPPEN-LUBINSKY SYNDROME	0.00816384	0.5461688508073081
MEHMO SYNDROME	0.00816384	0.5461688508073081
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.008151304	0.5453301801922887
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.008151304	0.5453301801922887
REFSUM DISEASE	0.00809822	0.5417788088674887
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.5320610409307254
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.5320610409307254
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.5320610409307254
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.5320610409307254
300270 ADRENOMYODYSTROPHY	0.007952964	0.5320610409307254
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00779868	0.5217392909971212
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00779868	0.5217392909971212
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00779868	0.5217392909971212
3-HYDROXYISOBUTYRIC ACIDURIA	0.00779868	0.5217392909971212
PSEUDO-TORCH SYNDROME 2	0.00779868	0.5217392909971212
DUPLICATION/INVERSION 15Q11	0.00776409	0.5194251862927879
MONOSOMY 22	0.00776409	0.5194251862927879
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00776409	0.5194251862927879
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00776409	0.5194251862927879
WIEDEMANN-STEINER SYNDROME	0.00776409	0.5194251862927879
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00776409	0.5194251862927879
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00776409	0.5194251862927879
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.007758620000000001	0.5190592379628457
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007758620000000001	0.5190592379628457
FAMILIAL COLORECTAL CANCER TYPE X	0.007758620000000001	0.5190592379628457
METACHROMATIC LEUKODYSTROPHY	0.007758620000000001	0.5190592379628457
ALEXANDER DISEASE	0.007758620000000001	0.5190592379628457
NEUROFERRITINOPATHY	0.007758620000000001	0.5190592379628457
CADASIL	0.007758620000000001	0.5190592379628457
BEHÇET DISEASE	0.007758620000000001	0.5190592379628457
CHOREOACANTHOCYTOSIS	0.007758620000000001	0.5190592379628457
ATAXIA WITH VITAMIN E DEFICIENCY	0.007758620000000001	0.5190592379628457
LYNCH SYNDROME	0.007758620000000001	0.5190592379628457
TRISOMY 18P	0.00765298	0.5119918190277264
TEEBI-SHALTOUT SYNDROME; TBSH	0.00765298	0.5119918190277264
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00765298	0.5119918190277264
MICROPHTHALMIA, SYNDROMIC 1	0.00765298	0.5119918190277264
HALLERMANN-STREIFF SYNDROME	0.00765298	0.5119918190277264
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00765298	0.5119918190277264
LEPRECHAUNISM	0.00765298	0.5119918190277264
COHEN SYNDROME	0.00765298	0.5119918190277264
OROFACIODIGITAL SYNDROME TYPE 5	0.00765298	0.5119918190277264
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00765298	0.5119918190277264
HALLERMANN-STREIFF SYNDROME; HSS	0.00765298	0.5119918190277264
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00765298	0.5119918190277264
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00765298	0.5119918190277264
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00765298	0.5119918190277264
SHPRINTZEN-GOLDBERG SYNDROME	0.00765298	0.5119918190277264
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00765298	0.5119918190277264
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.007587804	0.5076314811205385
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007587804	0.5076314811205385
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007587804	0.5076314811205385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.007587804	0.5076314811205385
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.007587804	0.5076314811205385
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007587804	0.5076314811205385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.007587804	0.5076314811205385
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.007587804	0.5076314811205385
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.007587804	0.5076314811205385
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.007587804	0.5076314811205385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.007587804	0.5076314811205385
NAVAJO NEUROHEPATOPATHY	0.007587804	0.5076314811205385
HYPOTONIA-CYSTINURIA SYNDROME	0.007587804	0.5076314811205385
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.007587804	0.5076314811205385
2P21 MICRODELETION SYNDROME	0.007587804	0.5076314811205385
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.007587804	0.5076314811205385
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007553214	0.5053173764162051
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007553214	0.5053173764162051
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.007553214	0.5053173764162051
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007553214	0.5053173764162051
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.007442104000000001	0.49788400915114356
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.007442104000000001	0.49788400915114356
6Q TERMINAL DELETION SYNDROME	0.007442104000000001	0.49788400915114356
OGDEN SYNDROME	0.007442104000000001	0.49788400915114356
BARDET-BIEDL SYNDROME 1; BBS1	0.007442104000000001	0.49788400915114356
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.007442104000000001	0.49788400915114356
DIGEORGE SYNDROME; DGS	0.007442104000000001	0.49788400915114356
OCCIPITAL HORN SYNDROME	0.007442104000000001	0.49788400915114356
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.007442104000000001	0.49788400915114356
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.007442104000000001	0.49788400915114356
3C SYNDROME	0.007442104000000001	0.49788400915114356
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.007442104000000001	0.49788400915114356
MUENKE SYNDROME	0.007442104000000001	0.49788400915114356
ADRENOMYODYSTROPHY	0.00740741	0.4955629467454731
2Q24 MICRODELETION SYNDROME	0.00740741	0.4955629467454731
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.4955629467454731
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.4955629467454731
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.4955629467454731
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.4955629467454731
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.4955629467454731
GABRIELE-DE VRIES SYNDROME	0.00740741	0.4955629467454731
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00740741	0.4955629467454731
1Q41Q42 MICRODELETION SYNDROME	0.00740741	0.4955629467454731
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00740741	0.4955629467454731
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.4955629467454731
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.4955629467454731
FRYNS SYNDROME	0.00740741	0.4955629467454731
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.4955629467454731
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.4955629467454731
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.4955629467454731
LISSENCEPHALY 5; LIS5	0.00740741	0.4955629467454731
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.4955629467454731
PITT-HOPKINS-LIKE SYNDROME	0.00740741	0.4955629467454731
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.4955629467454731
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.4955629467454731
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.4955629467454731
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.4955629467454731
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.4955629467454731
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.4955629467454731
KID SYNDROME	0.00740741	0.4955629467454731
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.4955629467454731
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007394874	0.4947242761304536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007394874	0.4947242761304536
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007394874	0.4947242761304536
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.007394874	0.4947242761304536
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.007394874	0.4947242761304536
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007394874	0.4947242761304536
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007394874	0.4947242761304536
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.007394874	0.4947242761304536
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007394874	0.4947242761304536
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007394874	0.4947242761304536
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007394874	0.4947242761304536
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.007394874	0.4947242761304536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0072436440000000005	0.48460684177265273
RING CHROMOSOME 22 SYNDROME	0.0072436440000000005	0.48460684177265273
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00723616	0.48410615488027836
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00723616	0.48410615488027836
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00723616	0.48410615488027836
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00704225	0.4711333869352861
GLYCOGEN STORAGE DISEASE IB	0.00704225	0.4711333869352861
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00704225	0.4711333869352861
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00704225	0.4711333869352861
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.4711333869352861
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00704225	0.4711333869352861
GLYCOGEN STORAGE DISEASE IA	0.00704225	0.4711333869352861
MAPLE SYRUP URINE DISEASE; MSUD	0.00704225	0.4711333869352861
GLYCOGEN STORAGE DISEASE IXC	0.00704225	0.4711333869352861
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.4711333869352861
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.4711333869352861
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00704225	0.4711333869352861
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.4711333869352861
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.4711333869352861
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.4711333869352861
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.4711333869352861
GRACILE SYNDROME	0.00704225	0.4711333869352861
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.4711333869352861
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00704225	0.4711333869352861
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00704225	0.4711333869352861
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00704225	0.4711333869352861
SUCCINIC ACIDEMIA	0.00704225	0.4711333869352861
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.4711333869352861
LICHTENSTEIN SYNDROME	0.007007660000000001	0.46881928223095276
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.007007660000000001	0.46881928223095276
CEREBROFACIOTHORACIC DYSPLASIA	0.007007660000000001	0.46881928223095276
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007007660000000001	0.46881928223095276
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.007007660000000001	0.46881928223095276
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.007007660000000001	0.46881928223095276
PHOCOMELIA, SCHINZEL TYPE	0.00689655	0.46138591496589126
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00689655	0.46138591496589126
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00689655	0.46138591496589126
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00689655	0.46138591496589126
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00689655	0.46138591496589126
CLEIDOCRANIAL DYSPLASIA	0.00689655	0.46138591496589126
MARFAN SYNDROME	0.00689655	0.46138591496589126
OROFACIODIGITAL SYNDROME XVII	0.00689655	0.46138591496589126
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00689655	0.46138591496589126
NEONATAL MARFAN SYNDROME	0.00689655	0.46138591496589126
CENANI-LENZ SYNDROME	0.00689655	0.46138591496589126
RADIO-RENAL SYNDROME	0.00689655	0.46138591496589126
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00689655	0.46138591496589126
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00689655	0.46138591496589126
FAMILIAL ANETODERMA	0.00689655	0.46138591496589126
OCULOPHARYNGODISTAL MYOPATHY	0.00689655	0.46138591496589126
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00689655	0.46138591496589126
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00689655	0.46138591496589126
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00689655	0.46138591496589126
STICKLER SYNDROME, TYPE II	0.00689655	0.46138591496589126
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00689655	0.46138591496589126
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00689655	0.46138591496589126
INTERMEDIATE NEMALINE MYOPATHY	0.00689655	0.46138591496589126
SIMOSA CRANIOFACIAL SYNDROME	0.00689655	0.46138591496589126
ACROPECTOROVERTEBRAL DYSPLASIA	0.00689655	0.46138591496589126
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00689655	0.46138591496589126
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00689655	0.46138591496589126
CLEIDOCRANIAL DYSPLASIA; CCD	0.00689655	0.46138591496589126
MARFANOID HYPERMOBILITY SYNDROME	0.00689655	0.46138591496589126
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00689655	0.46138591496589126
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00689655	0.46138591496589126
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00689655	0.46138591496589126
601095 HARROD SYNDROME	0.00689655	0.46138591496589126
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00684932	0.4582261819452013
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.4582261819452013
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.4582261819452013
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.4582261819452013
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.4582261819452013
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.4582261819452013
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.4582261819452013
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.4582261819452013
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.4582261819452013
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.4582261819452013
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.4582261819452013
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.4582261819452013
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00684932	0.4582261819452013
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.4582261819452013
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.4582261819452013
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.4582261819452013
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.4582261819452013
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.4582261819452013
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.4582261819452013
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.4582261819452013
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.4582261819452013
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.4582261819452013
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00684932	0.4582261819452013
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.4582261819452013
BARAITSER-WINTER SYNDROME 1; BRWS1	0.006721184	0.44965375869008545
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006721184	0.44965375869008545
CHROMOSOME 10Q26 DELETION SYNDROME	0.006721184	0.44965375869008545
14Q12 MICRODELETION SYNDROME	0.00669809	0.44810874758740044
KBG SYNDROME	0.006678324	0.44678638292750295
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.006678324	0.44678638292750295
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.006678324	0.44678638292750295
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006678324	0.44678638292750295
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006678324	0.44678638292750295
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006678324	0.44678638292750295
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.006678324	0.44678638292750295
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.006678324	0.44678638292750295
ALAZAMI-YUAN SYNDROME	0.006678324	0.44678638292750295
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.006678324	0.44678638292750295
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.006678324	0.44678638292750295
HOLOPROSENCEPHALY 11	0.006678324	0.44678638292750295
BOHRING-OPITZ SYNDROME	0.006678324	0.44678638292750295
12Q14 MICRODELETION SYNDROME	0.006678324	0.44678638292750295
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.44678638292750295
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.44678638292750295
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006678324	0.44678638292750295
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006678324	0.44678638292750295
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006487214	0.4340009377108176
1P36 DELETION SYNDROME	0.006381584000000001	0.4269341877854423
2P15P16.1 MICRODELETION SYNDROME	0.006381584	0.4269341877854423
PYRUVATE DEHYDROGENASE DEFICIENCY	0.006381584	0.4269341877854423
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00617563	0.41315566450483304
20P13 MICRODELETION SYNDROME	0.00613277	0.41028828874225065
2Q23.1 MICRODELETION SYNDROME	0.00613277	0.41028828874225065
PIEBALDISM	0.00613277	0.41028828874225065
9Q SUBTELOMERIC DELETION SYNDROME	0.00613277	0.41028828874225065
MICROTRIPLICATION 11Q24.1	0.00613277	0.41028828874225065
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.41028828874225065
BRANCHIOSKELETOGENITAL SYNDROME	0.00613277	0.41028828874225065
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.41028828874225065
CORNELIA DE LANGE SYNDROME	0.00613277	0.41028828874225065
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00613277	0.41028828874225065
XYLT1-CDG	0.00613277	0.41028828874225065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00613277	0.41028828874225065
NON-DISTAL TRISOMY 13Q	0.00613277	0.41028828874225065
KLEEFSTRA SYNDROME	0.00613277	0.41028828874225065
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0059218940000000005	0.3961804788656678
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0059218940000000005	0.3961804788656678
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0059218940000000005	0.3961804788656678
EVEN-PLUS SYNDROME	0.0059218940000000005	0.3961804788656678
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0059218940000000005	0.3961804788656678
ELSAHY-WATERS SYNDROME; ESWS	0.0059218940000000005	0.3961804788656678
DESANTO-SHINAWI SYNDROME	0.0059218940000000005	0.3961804788656678
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0059218940000000005	0.3961804788656678
11P15.4 MICRODUPLICATION SYNDROME	0.0059218940000000005	0.3961804788656678
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0059218940000000005	0.3961804788656678
GERMAN SYNDROME	0.0059218940000000005	0.3961804788656678
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.3961804788656678
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.3961804788656678
SMITH-MAGENIS SYNDROME; SMS	0.0059218940000000005	0.3961804788656678
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0059218940000000005	0.3961804788656678
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.3961804788656678
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.005836030000000001	0.39043609360019
TETRASOMY 18P	0.005836030000000001	0.39043609360019
OROFACIODIGITAL SYNDROME TYPE 6	0.005625154	0.37632828372360716
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.005625154	0.37632828372360716
COHEN-GIBSON SYNDROME; COGIS	0.005625154	0.37632828372360716
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005612324	0.3754699442221155
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.005612324	0.3754699442221155
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005612324	0.3754699442221155
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.005612324	0.3754699442221155
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005612324	0.3754699442221155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.005612324	0.3754699442221155
MULTIPLE SULFATASE DEFICIENCY	0.005612324	0.3754699442221155
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.005612324	0.3754699442221155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005612324	0.3754699442221155
AICARDI-GOUTIERES SYNDROME 6	0.005612324	0.3754699442221155
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005612324	0.3754699442221155
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005612324	0.3754699442221155
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.005612324	0.3754699442221155
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005612324	0.3754699442221155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005612324	0.3754699442221155
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.005612324	0.3754699442221155
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.005612324	0.3754699442221155
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.005612324	0.3754699442221155
ALPERS-HUTTENLOCHER SYNDROME	0.005612324	0.3754699442221155
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005612324	0.3754699442221155
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005612324	0.3754699442221155
EDINBURGH MALFORMATION SYNDROME	0.00537634	0.3596823846804155
PRIMROSE SYNDROME; PRIMS	0.00537634	0.3596823846804155
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.3596823846804155
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00537634	0.3596823846804155
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.3596823846804155
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.3596823846804155
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.3596823846804155
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.3596823846804155
ISOLATED TRIGONOCEPHALY	0.00537634	0.3596823846804155
WAARDENBURG SYNDROME	0.00537634	0.3596823846804155
MCDONOUGH SYNDROME	0.00537634	0.3596823846804155
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00537634	0.3596823846804155
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.3596823846804155
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.3596823846804155
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00537634	0.3596823846804155
GASTROCUTANEOUS SYNDROME	0.00537634	0.3596823846804155
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00537634	0.3596823846804155
17Q24.2 MICRODELETION SYNDROME	0.00537634	0.3596823846804155
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.3596823846804155
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.3596823846804155
MARSHALL-SMITH SYNDROME; MRSHSS	0.00537634	0.3596823846804155
ZIMMERMANN-LABAND SYNDROME 1	0.00537634	0.3596823846804155
ACROMEGALY	0.00537634	0.3596823846804155
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00537634	0.3596823846804155
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00537634	0.3596823846804155
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00537634	0.3596823846804155
SOMATOMAMMOTROPINOMA	0.00537634	0.3596823846804155
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00537634	0.3596823846804155
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00537634	0.3596823846804155
MENTAL RETARDATION, X-LINKED 21	0.00537634	0.3596823846804155
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00537634	0.3596823846804155
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.3596823846804155
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.3596823846804155
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.3596823846804155
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.3596823846804155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.3596823846804155
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.3596823846804155
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.3596823846804155
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00537634	0.3596823846804155
WAARDENBURG SYNDROME TYPE 1	0.00537634	0.3596823846804155
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00537634	0.3596823846804155
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.3596823846804155
WAARDENBURG-SHAH SYNDROME	0.00537634	0.3596823846804155
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.3596823846804155
TRANSALDOLASE DEFICIENCY	0.00537634	0.3596823846804155
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.3596823846804155
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.3596823846804155
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00537634	0.3596823846804155
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00537634	0.3596823846804155
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005089864	0.3405168611395482
EMANUEL SYNDROME	0.0050898639999999995	0.3405168611395481
MYOTONIA PERMANENS	0.0050796	0.33983018953835487
MOEBIUS SYNDROME; MBS	0.0050796	0.33983018953835487
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0050796	0.33983018953835487
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00506677	0.3389718500368632
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00506677	0.3389718500368632
RETT SYNDROME	0.00506677	0.3389718500368632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00506677	0.3389718500368632
NORRIE DISEASE	0.00506677	0.3389718500368632
TRIPLE A SYNDROME	0.00506677	0.3389718500368632
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00506677	0.3389718500368632
XERODERMA PIGMENTOSUM	0.00506677	0.3389718500368632
CHÉDIAK-HIGASHI SYNDROME	0.004855894	0.32486404016028037
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.004855894	0.32486404016028037
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.004855894	0.32486404016028037
MUCOPOLYSACCHARIDOSIS TYPE 2	0.004855894	0.32486404016028037
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.004855894	0.32486404016028037
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.004855894	0.32486404016028037
TAY-SACHS DISEASE	0.004855894	0.32486404016028037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.004855894	0.32486404016028037
SCHINDLER DISEASE, TYPE I	0.004855894	0.32486404016028037
MYOCLONIC EPILEPSY OF INFANCY	0.004855894	0.32486404016028037
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004855894	0.32486404016028037
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004855894	0.32486404016028037
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.004855894	0.32486404016028037
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.004855894	0.32486404016028037
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.32486404016028037
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004855894	0.32486404016028037
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.32486404016028037
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004855894	0.32486404016028037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004855894	0.32486404016028037
MYOCLONIC-ASTASTIC EPILEPSY	0.004855894	0.32486404016028037
OPTIC PATHWAY GLIOMA	0.004855894	0.32486404016028037
CANAVAN DISEASE	0.004855894	0.32486404016028037
ZTTK SYNDROME; ZTTKS	0.004855894	0.32486404016028037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.004855894	0.32486404016028037
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004855894	0.32486404016028037
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004855894	0.32486404016028037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004855894	0.32486404016028037
3Q29 MICRODELETION SYNDROME	0.004750264000000001	0.3177972902349051
16P13.2 MICRODELETION SYNDROME	0.004750264000000001	0.3177972902349051
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004750264000000001	0.3177972902349051
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004750264000000001	0.3177972902349051
RIDDLE SYNDROME	0.004750264000000001	0.3177972902349051
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.30401876695429586
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.30401876695429586
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.30401876695429586
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00454431	0.30401876695429586
46,XX GONADAL DYSGENESIS	0.00454431	0.30401876695429586
XYLOSIDASE DEFICIENCY	0.00454431	0.30401876695429586
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.289910957077713
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.289910957077713
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004333434	0.289910957077713
REVESZ SYNDROME	0.004333434	0.289910957077713
SALLA DISEASE	0.004333434	0.289910957077713
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004333434	0.289910957077713
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004333434	0.289910957077713
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004333434	0.289910957077713
LARSEN-LIKE SYNDROME	0.004333434	0.289910957077713
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.289910957077713
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.28836594597502807
WOLFRAM SYNDROME	0.00431034	0.28836594597502807
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.00431034	0.28836594597502807
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00431034	0.28836594597502807
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00431034	0.28836594597502807
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00431034	0.28836594597502807
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.28836594597502807
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.28836594597502807
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00431034	0.28836594597502807
SNEDDON SYNDROME	0.00431034	0.28836594597502807
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00431034	0.28836594597502807
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00431034	0.28836594597502807
WHIPPLE DISEASE	0.00431034	0.28836594597502807
DYSOSTEOSCLEROSIS	0.00431034	0.28836594597502807
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.28836594597502807
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.28836594597502807
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.28836594597502807
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00431034	0.28836594597502807
DYSOSTEOSCLEROSIS	0.00431034	0.28836594597502807
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.28836594597502807
ALEXANDER DISEASE	0.00431034	0.28836594597502807
NASU-HAKOLA DISEASE	0.00431034	0.28836594597502807
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.28836594597502807
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00431034	0.28836594597502807
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00431034	0.28836594597502807
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.28836594597502807
CHILDHOOD DISINTEGRATIVE DISORDER	0.00431034	0.28836594597502807
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.28836594597502807
WEST SYNDROME	0.00431034	0.28836594597502807
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.28836594597502807
TRISOMY 5P	0.00431034	0.28836594597502807
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.28836594597502807
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00431034	0.28836594597502807
ADIPOSIS DOLOROSA	0.00431034	0.28836594597502807
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.28836594597502807
CARNOSINASE DEFICIENCY	0.00431034	0.28836594597502807
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00431034	0.28836594597502807
PANDAS	0.00431034	0.28836594597502807
GAUCHER DISEASE	0.00431034	0.28836594597502807
KRABBE DISEASE	0.00431034	0.28836594597502807
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00431034	0.28836594597502807
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00431034	0.28836594597502807
CEREBROTENDINOUS XANTHOMATOSIS	0.00431034	0.28836594597502807
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.28836594597502807
MUCOLIPIDOSIS TYPE IV	0.00420471	0.28129919604965276
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00420471	0.28129919604965276
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00420471	0.28129919604965276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00420471	0.28129919604965276
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00420471	0.28129919604965276
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00420471	0.28129919604965276
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00420471	0.28129919604965276
FRIED SYNDROME	0.003993834	0.2671913861730699
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.2671913861730699
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003993834	0.2671913861730699
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.2671913861730699
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.003993834	0.2671913861730699
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003993834	0.2671913861730699
INCONTINENTIA PIGMENTI	0.003993834	0.2671913861730699
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.2671913861730699
KRABBE DISEASE	0.003993834	0.2671913861730699
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.003993834	0.2671913861730699
JOUBERT SYNDROME 24	0.003993834	0.2671913861730699
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.2671913861730699
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003993834	0.2671913861730699
JOUBERT SYNDROME	0.003993834	0.2671913861730699
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.2671913861730699
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003993834	0.2671913861730699
FREE SIALIC ACID STORAGE DISEASE	0.003993834	0.2671913861730699
JOUBERT SYNDROME WITH RENAL DEFECT	0.003993834	0.2671913861730699
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.2671913861730699
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.003993834	0.2671913861730699
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003993834	0.2671913861730699
L1 SYNDROME	0.003993834	0.2671913861730699
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.003993834	0.2671913861730699
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.2671913861730699
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.2671913861730699
FOIX-CHAVANY-MARIE SYNDROME	0.003993834	0.2671913861730699
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.25341286289246073
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.25341286289246073
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.25341286289246073
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.25341286289246073
CARBOXYLESTERASE 1	0.00378788	0.25341286289246073
FLOOD FACTOR DEFICIENCY	0.00378788	0.25341286289246073
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.25341286289246073
BEETURIA	0.00378788	0.25341286289246073
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.25341286289246073
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.25341286289246073
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.25341286289246073
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.25341286289246073
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.25341286289246073
GLOMUVENOUS MALFORMATIONS	0.00378788	0.25341286289246073
GLUTATHIONE REDUCTASE	0.00378788	0.25341286289246073
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.25341286289246073
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.25341286289246073
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.25341286289246073
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.25341286289246073
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.25341286289246073
XANTHINURIA, TYPE I	0.00378788	0.25341286289246073
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.25341286289246073
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.25341286289246073
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.25341286289246073
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.25341286289246073
COUMARIN RESISTANCE	0.00378788	0.25341286289246073
T-SUBSTANCE ANOMALY	0.00378788	0.25341286289246073
BARTTER SYNDROME	0.00378788	0.25341286289246073
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.25341286289246073
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.25341286289246073
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.25341286289246073
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.25341286289246073
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.25341286289246073
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.25341286289246073
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.25341286289246073
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.25341286289246073
PENDRED SYNDROME	0.00378788	0.25341286289246073
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.25341286289246073
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.25341286289246073
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.25341286289246073
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.25341286289246073
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.25341286289246073
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.25341286289246073
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.25341286289246073
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.25341286289246073
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.25341286289246073
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.25341286289246073
HEINZ BODY ANEMIAS	0.00378788	0.25341286289246073
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.25341286289246073
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.25341286289246073
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.25341286289246073
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.25341286289246073
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.25341286289246073
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.25341286289246073
CITRULLINE TRANSPORT DEFECT	0.00378788	0.25341286289246073
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.25341286289246073
DERMATITIS, ATOPIC	0.00378788	0.25341286289246073
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.25341286289246073
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.25341286289246073
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.25341286289246073
PREMATURE OVARIAN FAILURE 1	0.00378788	0.25341286289246073
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.25341286289246073
OSTEOGENIC SARCOMA	0.00378788	0.25341286289246073
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.25341286289246073
CEPHALIN LIPIDOSIS	0.00378788	0.25341286289246073
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.25341286289246073
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.25341286289246073
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.25341286289246073
MYOPATHY, SPHEROID BODY	0.00378788	0.25341286289246073
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.25341286289246073
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.25341286289246073
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.25341286289246073
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.25341286289246073
DERMATOLEUKODYSTROPHY	0.00378788	0.25341286289246073
ICHTHYOSIS, X-LINKED	0.00378788	0.25341286289246073
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.25341286289246073
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.25341286289246073
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.25341286289246073
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.25341286289246073
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.25341286289246073
XM SYSTEM	0.00378788	0.25341286289246073
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.25341286289246073
AREDYLD	0.00378788	0.25341286289246073
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.25341286289246073
ALKAPTONURIA	0.00378788	0.25341286289246073
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.25341286289246073
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.25341286289246073
TRISOMY 18-LIKE SYNDROME	0.00378788	0.25341286289246073
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.25341286289246073
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.25341286289246073
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.25341286289246073
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.25341286289246073
SCHIZOPHRENIA 4	0.00378788	0.25341286289246073
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.25341286289246073
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.25341286289246073
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.25341286289246073
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.25341286289246073
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.25341286289246073
DELETED IN AZOOSPERMIA	0.00378788	0.25341286289246073
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.25341286289246073
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.25341286289246073
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.25341286289246073
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.25341286289246073
ZINC, ELEVATED PLASMA	0.00378788	0.25341286289246073
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.25341286289246073
MACROCYTOSIS, FAMILIAL	0.00378788	0.25341286289246073
ONCOCYTOMA	0.00378788	0.25341286289246073
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.25341286289246073
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.25341286289246073
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.25341286289246073
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.25341286289246073
PROGESTERONE RESISTANCE	0.00378788	0.25341286289246073
GONADOBLASTOMA	0.00378788	0.25341286289246073
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.25341286289246073
FINGERPRINT BODY MYOPATHY	0.00378788	0.25341286289246073
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.25341286289246073
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.25341286289246073
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.25341286289246073
LARON SYNDROME	0.00378788	0.25341286289246073
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.25341286289246073
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.25341286289246073
MACULAR CORNEAL DYSTROPHY	0.00378788	0.25341286289246073
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.25341286289246073
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.25341286289246073
PYGMY	0.00378788	0.25341286289246073
HYPOASCORBEMIA	0.00378788	0.25341286289246073
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.25341286289246073
ACETYLATION, SLOW	0.00378788	0.25341286289246073
OSTEOMESOPYKNOSIS	0.00378788	0.25341286289246073
ALAND ISLAND EYE DISEASE	0.00378788	0.25341286289246073
APOLIPOPROTEIN(A)	0.00378788	0.25341286289246073
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.25341286289246073
HOOFT DISEASE	0.00378788	0.25341286289246073
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.25341286289246073
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.25341286289246073
LIPASE DEFICIENCY, COMBINED	0.00378788	0.25341286289246073
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.25341286289246073
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.25341286289246073
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.25341286289246073
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.25341286289246073
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.25341286289246073
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.25341286289246073
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.25341286289246073
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.25341286289246073
HYPERPROGLUCAGONEMIA	0.00378788	0.25341286289246073
LYMPHOKINE DEFICIENCY	0.00378788	0.25341286289246073
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.25341286289246073
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.25341286289246073
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.25341286289246073
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.25341286289246073
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.25341286289246073
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.25341286289246073
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.25341286289246073
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.25341286289246073
ETHANOLAMINOSIS	0.00378788	0.25341286289246073
CALVARIAL HYPEROSTOSIS	0.00378788	0.25341286289246073
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.25341286289246073
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.25341286289246073
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.25341286289246073
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.25341286289246073
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.25341286289246073
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.25341286289246073
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.25341286289246073
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.25341286289246073
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.25341286289246073
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.25341286289246073
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.25341286289246073
PARAOXONASE 1	0.00378788	0.25341286289246073
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.25341286289246073
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.25341286289246073
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.25341286289246073
PITUITARY DWARFISM IV	0.00378788	0.25341286289246073
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.25341286289246073
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.25341286289246073
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.25341286289246073
GLUTATHIONURIA	0.00378788	0.25341286289246073
OVARIAN CANCER	0.00378788	0.25341286289246073
PACMAN DYSPLASIA	0.00378788	0.25341286289246073
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.25341286289246073
PERRY SYNDROME	0.00378788	0.25341286289246073
MYOCLONIC EPILEPSY OF LAFORA	0.00344828	0.2306932919878176
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.2306932919878176
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.2306932919878176
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.2306932919878176
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.2306932919878176
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.2306932919878176
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.2306932919878176
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.2306932919878176
RICHARDS-RUNDLE SYNDROME	0.00344828	0.2306932919878176
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.2306932919878176
OSTEOCHONDRITIS DISSECANS	0.00344828	0.2306932919878176
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.2306932919878176
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.2306932919878176
HEREDITARY HYPEREKPLEXIA	0.00344828	0.2306932919878176
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.2306932919878176
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.2306932919878176
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.2306932919878176
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.2306932919878176
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00344828	0.2306932919878176
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.2306932919878176
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.2306932919878176
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.2306932919878176
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.2306932919878176
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.2306932919878176
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.2306932919878176
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.2306932919878176
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.2306932919878176
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.2306932919878176
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.2306932919878176
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.2306932919878176
ROUSSY-LÉVY SYNDROME	0.00344828	0.2306932919878176
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.2306932919878176
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.2306932919878176
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00344828	0.2306932919878176
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.2306932919878176
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.2306932919878176
MYOTONIA FLUCTUANS	0.00344828	0.2306932919878176
LERI PLEONOSTEOSIS	0.00344828	0.2306932919878176
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.2306932919878176
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.2306932919878176
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.2306932919878176
SUBEPENDYMOMA	0.00344828	0.2306932919878176
EPENDYMOMA	0.00344828	0.2306932919878176
MAST SYNDROME	0.00344828	0.2306932919878176
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.2306932919878176
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.2306932919878176
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.2306932919878176
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.2306932919878176
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.2306932919878176
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.2306932919878176
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.2306932919878176
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.2306932919878176
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.2306932919878176
METACHROMATIC LEUKODYSTROPHY	0.00344828	0.2306932919878176
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.2306932919878176
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00344828	0.2306932919878176
BENIGN HEREDITARY CHOREA	0.00344828	0.2306932919878176
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.2306932919878176
SPONASTRIME DYSPLASIA	0.00344828	0.2306932919878176
FAMILIAL DYSAUTONOMIA	0.00344828	0.2306932919878176
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.2306932919878176
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.2306932919878176
MASA SYNDROME	0.00344828	0.2306932919878176
BEHR SYNDROME	0.00344828	0.2306932919878176
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.2306932919878176
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00344828	0.2306932919878176
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.2306932919878176
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.2306932919878176
CYSTINOSIS	0.00344828	0.2306932919878176
DYSEQUILIBRIUM SYNDROME	0.00344828	0.2306932919878176
ADULT POLYGLUCOSAN BODY DISEASE	0.00344828	0.2306932919878176
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00344828	0.2306932919878176
PARTINGTON SYNDROME	0.00344828	0.2306932919878176
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.2306932919878176
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.2306932919878176
THORACOMELIC DYSPLASIA	0.00344828	0.2306932919878176
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.2306932919878176
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.2306932919878176
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.2306932919878176
ATAXIA-TELANGIECTASIA	0.00344828	0.2306932919878176
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.2306932919878176
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00344828	0.2306932919878176
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.2306932919878176
GAUCHER DISEASE TYPE 3	0.00344828	0.2306932919878176
KENNEDY DISEASE	0.00344828	0.2306932919878176
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.2306932919878176
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.2306932919878176
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.2306932919878176
NONAKA MYOPATHY	0.00344828	0.2306932919878176
DYSTONIA 16; DYT16	0.00344828	0.2306932919878176
KALLMANN SYNDROME	0.00344828	0.2306932919878176
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.2306932919878176
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.2306932919878176
DYSTONIA 23; DYT23	0.00344828	0.2306932919878176
PSEUDOACHONDROPLASIA	0.00344828	0.2306932919878176
X-LINKED CENTRONUCLEAR MYOPATHY	0.00344828	0.2306932919878176
CENTRONUCLEAR MYOPATHY	0.00344828	0.2306932919878176
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.2306932919878176
OSTEOGENESIS IMPERFECTA	0.00344828	0.2306932919878176
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.2306932919878176
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.2306932919878176
POLYMYOSITIS	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00344828	0.2306932919878176
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00344828	0.2306932919878176
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.2306932919878176
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.2306932919878176
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.2306932919878176
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.2306932919878176
KUFOR-RAKEB SYNDROME	0.00344828	0.2306932919878176
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.2306932919878176
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00344828	0.2306932919878176
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.2306932919878176
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.2306932919878176
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.2306932919878176
ALZHEIMER DISEASE 3; AD	0.00344828	0.2306932919878176
SIALIDOSIS TYPE 1	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.2306932919878176
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.2306932919878176
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.2306932919878176
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.2306932919878176
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.2306932919878176
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00344828	0.2306932919878176
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00344828	0.2306932919878176
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.2306932919878176
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.2306932919878176
MUSCLE-EYE-BRAIN DISEASE	0.00344828	0.2306932919878176
MELNICK-NEEDLES SYNDROME	0.00344828	0.2306932919878176
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.2306932919878176
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.2306932919878176
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.2306932919878176
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.2306932919878176
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.2306932919878176
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.2306932919878176
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00344828	0.2306932919878176
NEMALINE MYOPATHY 6	0.00344828	0.2306932919878176
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.2306932919878176
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00344828	0.2306932919878176
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00344828	0.2306932919878176
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.2306932919878176
BRITTLE CORNEA SYNDROME	0.00344828	0.2306932919878176
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.2306932919878176
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.2306932919878176
CLASSIC GALACTOSEMIA	0.00344828	0.2306932919878176
KUSKOKWIM SYNDROME	0.00344828	0.2306932919878176
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.2306932919878176
CORTICOBASAL SYNDROME	0.00344828	0.2306932919878176
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0029333040000000003	0.19624089579762471
RING CHROMOSOME 14 SYNDROME	0.0029333040000000003	0.19624089579762471
FANCONI ANEMIA	0.0029333040000000003	0.19624089579762471
ROTHMUND-THOMSON SYNDROME	0.0029333040000000003	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029333040000000003	0.19624089579762471
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0029333040000000003	0.19624089579762471
DISTAL MONOSOMY 1Q	0.0029333040000000003	0.19624089579762471
SMITH-LEMLI-OPITZ SYNDROME	0.0029333040000000003	0.19624089579762471
PHENOBARBITAL EMBRYOPATHY	0.0029333040000000003	0.19624089579762471
22Q11.2 DELETION SYNDROME	0.0029333040000000003	0.19624089579762471
DISTAL MONOSOMY 10Q	0.0029333040000000003	0.19624089579762471
19P13.3 MICRODUPLICATION SYNDROME	0.002933304	0.19624089579762471
15Q24 MICRODELETION SYNDROME	0.002933304	0.19624089579762471
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.002933304	0.19624089579762471
RUBINSTEIN-TAYBI SYNDROME	0.002933304	0.19624089579762471
10Q22.3Q23.3 MICRODELETION SYNDROME	0.002933304	0.19624089579762471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.002933304	0.19624089579762471
TOLUENE EMBRYOPATHY	0.002933304	0.19624089579762471
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002933304	0.19624089579762471
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.002933304	0.19624089579762471
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002933304	0.19624089579762471
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002933304	0.19624089579762471
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002933304	0.19624089579762471
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002933304	0.19624089579762471
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002933304	0.19624089579762471
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.002933304	0.19624089579762471
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.002933304	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.002933304	0.19624089579762471
MONOSOMY 18Q	0.002933304	0.19624089579762471
MONOSOMY 18P	0.002933304	0.19624089579762471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002933304	0.19624089579762471
FETAL ALCOHOL SYNDROME	0.002933304	0.19624089579762471
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002933304	0.19624089579762471
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.002933304	0.19624089579762471
OGDEN SYNDROME; OGDNS	0.002933304	0.19624089579762471
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.002933304	0.19624089579762471
HOLMES-GANG SYNDROME	0.002933304	0.19624089579762471
CEREBROFACIOARTICULAR SYNDROME	0.002933304	0.19624089579762471
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.002933304	0.19624089579762471
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.002933304	0.19624089579762471
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.002933304	0.19624089579762471
22Q11.2 MICRODUPLICATION SYNDROME	0.002933304	0.19624089579762471
6Q16 MICRODELETION SYNDROME	0.002933304	0.19624089579762471
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.002933304	0.19624089579762471
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.002933304	0.19624089579762471
DISTAL TRISOMY 17Q	0.002933304	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.002933304	0.19624089579762471
C SYNDROME	0.002933304	0.19624089579762471
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.002933304	0.19624089579762471
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.002933304	0.19624089579762471
MATERNAL PHENYLKETONURIA	0.002933304	0.19624089579762471
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.002933304	0.19624089579762471
LATHOSTEROLOSIS	0.002933304	0.19624089579762471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.002933304	0.19624089579762471
MONOSOMY 13Q34	0.002933304	0.19624089579762471
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.002933304	0.19624089579762471
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.002933304	0.19624089579762471
HADZISELIMOVIC SYNDROME	0.002933304	0.19624089579762471
WARSAW BREAKAGE SYNDROME; WABS	0.002933304	0.19624089579762471
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.002933304	0.19624089579762471
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002933304	0.19624089579762471
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.002933304	0.19624089579762471
CHARGE SYNDROME	0.002933304	0.19624089579762471
1Q21.1 MICRODELETION SYNDROME	0.002933304	0.19624089579762471
HARTSFIELD SYNDROME; HRTFDS	0.002933304	0.19624089579762471
LIG4 SYNDROME	0.002933304	0.19624089579762471
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002933304	0.19624089579762471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.002933304	0.19624089579762471
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.002933304	0.19624089579762471
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002933304	0.19624089579762471
COFFIN-SIRIS SYNDROME	0.002933304	0.19624089579762471
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.002933304	0.19624089579762471
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.002933304	0.19624089579762471
CK SYNDROME	0.002933304	0.19624089579762471
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.002933304	0.19624089579762471
6Q25 MICRODELETION SYNDROME	0.002933304	0.19624089579762471
8P11.2 DELETION SYNDROME	0.002933304	0.19624089579762471
8P23.1 MICRODELETION SYNDROME	0.002933304	0.19624089579762471
20Q11.2 MICRODUPLICATION SYNDROME	0.002933304	0.19624089579762471
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.002933304	0.19624089579762471
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.002933304	0.19624089579762471
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.002933304	0.19624089579762471
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00238775	0.1597428016123724
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00238775	0.1597428016123724
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00238775	0.1597428016123724
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00238775	0.1597428016123724
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00238775	0.1597428016123724
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00238775	0.1597428016123724
DIAMOND-BLACKFAN ANEMIA 1	0.00238775	0.1597428016123724
FEINGOLD SYNDROME 1; FGLDS1	0.00238775	0.1597428016123724
MARTSOLF SYNDROME	0.00238775	0.1597428016123724
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00238775	0.1597428016123724
RING CHROMOSOME 13 SYNDROME	0.00238775	0.1597428016123724
OROFACIODIGITAL SYNDROME I; OFD1	0.00238775	0.1597428016123724
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00238775	0.1597428016123724
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00238775	0.1597428016123724
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00238775	0.1597428016123724
DUBOWITZ SYNDROME	0.00238775	0.1597428016123724
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00238775	0.1597428016123724
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00238775	0.1597428016123724
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00238775	0.1597428016123724
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00238775	0.1597428016123724
CHROMOSOME 18Q DELETION SYNDROME	0.00238775	0.1597428016123724
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00238775	0.1597428016123724
GMS SYNDROME	0.00238775	0.1597428016123724
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00238775	0.1597428016123724
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00238775	0.1597428016123724
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00238775	0.1597428016123724
DUBOWITZ SYNDROME	0.00238775	0.1597428016123724
DISTAL TRISOMY 5Q	0.00238775	0.1597428016123724
C SYNDROME	0.00238775	0.1597428016123724
PRIMARY PULMONARY HYPOPLASIA	0.00238775	0.1597428016123724
COFFIN-SIRIS SYNDROME 10; CSS10	0.00238775	0.1597428016123724
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00238775	0.1597428016123724
CAREY-FINEMAN-ZITER SYNDROME	0.00238775	0.1597428016123724
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00238775	0.1597428016123724
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00238775	0.1597428016123724
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00238775	0.1597428016123724
JACOBSEN SYNDROME	0.00238775	0.1597428016123724
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00238775	0.1597428016123724
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00238775	0.1597428016123724
DISTAL MONOSOMY 3P	0.00238775	0.1597428016123724
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00238775	0.1597428016123724
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00238775	0.1597428016123724
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00238775	0.1597428016123724
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00238775	0.1597428016123724
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00238775	0.1597428016123724
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00238775	0.1597428016123724
RING CHROMOSOME 6 SYNDROME	0.00238775	0.1597428016123724
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00238775	0.1597428016123724
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00238775	0.1597428016123724
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00238775	0.1597428016123724
MONOSOMY 13Q14	0.00238775	0.1597428016123724
ACHALASIA-MICROCEPHALY SYNDROME	0.00238775	0.1597428016123724
LATHOSTEROLOSIS	0.00238775	0.1597428016123724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00238775	0.1597428016123724
CRI-DU-CHAT SYNDROME	0.00238775	0.1597428016123724
DESMOSTEROLOSIS	0.00238775	0.1597428016123724
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.14563499173578953
TETRASOMY 9P	0.0021768739999999996	0.14563499173578953
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.14563499173578953
DISTAL MONOSOMY 6P	0.0021768739999999996	0.14563499173578953
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.14563499173578953
20P12.3 MICRODELETION SYNDROME	0.0021768739999999996	0.14563499173578953
TETRASOMY 5P	0.0021768739999999996	0.14563499173578953
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0021768739999999996	0.14563499173578953
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.14563499173578953
CARDIOFACIOCUTANEOUS SYNDROME	0.0021768739999999996	0.14563499173578953
48,XXYY SYNDROME	0.0021768739999999996	0.14563499173578953
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.14563499173578953
COSTELLO SYNDROME; CSTLO	0.0021768739999999996	0.14563499173578953
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.14563499173578953
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.14563499173578953
XQ25 DUPLICATION SYNDROME	0.0021768739999999996	0.14563499173578953
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0021768739999999996	0.14563499173578953
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.14563499173578953
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.14563499173578953
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0021768739999999996	0.14563499173578953
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0021768739999999996	0.14563499173578953
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0021768739999999996	0.14563499173578953
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.14563499173578953
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.14563499173578953
XQ25 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.14563499173578953
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0021768739999999996	0.14563499173578953
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.14563499173578953
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.14563499173578953
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.14563499173578953
POTOCKI-SHAFFER SYNDROME	0.0021768739999999996	0.14563499173578953
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.14563499173578953
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0021768739999999996	0.14563499173578953
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.14563499173578953
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.14563499173578953
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0021768739999999996	0.14563499173578953
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.14563499173578953
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.14563499173578953
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021768739999999996	0.14563499173578953
OROFACIODIGITAL SYNDROME VI	0.0021768739999999996	0.14563499173578953
BAKER-GORDON SYNDROME; BAGOS	0.0021768739999999996	0.14563499173578953
TRISOMY X	0.0021768739999999996	0.14563499173578953
CHROMOSOME 16Q22 DELETION SYNDROME	0.0021768739999999996	0.14563499173578953
JOUBERT SYNDROME 14	0.0021768739999999996	0.14563499173578953
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.14563499173578953
PSEUDOAMINOPTERIN SYNDROME	0.0021768739999999996	0.14563499173578953
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.14563499173578953
PMM2-CDG	0.0021768739999999996	0.14563499173578953
ICF SYNDROME	0.0021768739999999996	0.14563499173578953
WEAVER SYNDROME	0.0021768739999999996	0.14563499173578953
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.14563499173578953
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.14563499173578953
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0021768739999999996	0.14563499173578953
48,XXXY SYNDROME	0.0021768739999999996	0.14563499173578953
14Q22Q23 MICRODELETION SYNDROME	0.0021768739999999996	0.14563499173578953
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.14563499173578953
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.14563499173578953
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.14563499173578953
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0021768739999999996	0.14563499173578953
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0021768739999999996	0.14563499173578953
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.14563499173578953
JOUBERT SYNDROME 10	0.0021768739999999996	0.14563499173578953
TRISOMY 12P	0.0021768739999999996	0.14563499173578953
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0021768739999999996	0.14563499173578953
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021768739999999996	0.14563499173578953
X SMALL RINGS	0.0021768739999999996	0.14563499173578953
MONOSOMY 22Q13.3	0.0021768739999999996	0.14563499173578953
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0021768739999999996	0.14563499173578953
15Q11Q13 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.14563499173578953
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.14563499173578953
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.14563499173578953
8Q12 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.14563499173578953
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0021768739999999996	0.14563499173578953
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0021768739999999996	0.14563499173578953
19P13.13 MICRODELETION SYNDROME	0.0021768739999999996	0.14563499173578953
INFANTILE SIALIC ACID STORAGE DISEASE	0.0021768739999999996	0.14563499173578953
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0021768739999999996	0.14563499173578953
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0021768739999999996	0.14563499173578953
TETRASOMY X	0.0021768739999999996	0.14563499173578953
LAMB-SHAFFER SYNDROME	0.0021768739999999996	0.14563499173578953
48,XYYY SYNDROME	0.0021768739999999996	0.14563499173578953
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0021768739999999996	0.14563499173578953
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.14563499173578953
MONOSOMY 9Q22.3	0.0021768739999999996	0.14563499173578953
JOUBERT SYNDROME 1	0.0021768739999999996	0.14563499173578953
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.14563499173578953
49,XXXXY SYNDROME	0.0021768739999999996	0.14563499173578953
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021768739999999996	0.14563499173578953
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.14563499173578953
CODAS SYNDROME	0.0021768739999999996	0.14563499173578953
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.10913689755053724
SUMMITT SYNDROME	0.00163132	0.10913689755053724
MOMO SYNDROME	0.00163132	0.10913689755053724
KEIPERT SYNDROME	0.00163132	0.10913689755053724
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.10913689755053724
OROFACIODIGITAL SYNDROME TYPE 1	0.00163132	0.10913689755053724
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00163132	0.10913689755053724
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.10913689755053724
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.10913689755053724
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.10913689755053724
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.10913689755053724
LAURENCE-MOON SYNDROME	0.00163132	0.10913689755053724
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.10913689755053724
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.10913689755053724
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00163132	0.10913689755053724
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.10913689755053724
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.10913689755053724
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.10913689755053724
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.10913689755053724
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.10913689755053724
20Q13.33 MICRODELETION SYNDROME	0.00163132	0.10913689755053724
JOUBERT SYNDROME 3; JBTS3	0.00163132	0.10913689755053724
OROFACIAL CLEFT 15	0.00163132	0.10913689755053724
ACROCALLOSAL SYNDROME; ACLS	0.00163132	0.10913689755053724
ATELOSTEOGENESIS TYPE II	0.00163132	0.10913689755053724
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00163132	0.10913689755053724
NOONAN SYNDROME 8; NS8	0.00163132	0.10913689755053724
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.10913689755053724
STICKLER SYNDROME	0.00163132	0.10913689755053724
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.10913689755053724
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.10913689755053724
PTERYGIUM COLLI, ISOLATED	0.00163132	0.10913689755053724
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.10913689755053724
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00163132	0.10913689755053724
MILROY DISEASE	0.00163132	0.10913689755053724
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00163132	0.10913689755053724
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.10913689755053724
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00163132	0.10913689755053724
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.10913689755053724
POTOCKI-SHAFFER SYNDROME	0.00163132	0.10913689755053724
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.10913689755053724
NOONAN SYNDROME 4; NS4	0.00163132	0.10913689755053724
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.10913689755053724
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.10913689755053724
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.10913689755053724
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.10913689755053724
ZUNICH NEUROECTODERMAL SYNDROME	0.00163132	0.10913689755053724
SCARF SYNDROME	0.00163132	0.10913689755053724
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.10913689755053724
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.10913689755053724
EPICANTHUS	0.00163132	0.10913689755053724
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.10913689755053724
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.10913689755053724
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.10913689755053724
MOEBIUS SYNDROME	0.00163132	0.10913689755053724
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.10913689755053724
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00163132	0.10913689755053724
CHIME SYNDROME	0.00163132	0.10913689755053724
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.10913689755053724
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.10913689755053724
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.10913689755053724
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.10913689755053724
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.10913689755053724
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.10913689755053724
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00163132	0.10913689755053724
PHAVER SYNDROME	0.00163132	0.10913689755053724
3Q13 MICRODELETION SYNDROME	0.00163132	0.10913689755053724
OHDO SYNDROME	0.00163132	0.10913689755053724
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.10913689755053724
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.10913689755053724
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.10913689755053724
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.10913689755053724
OMODYSPLASIA 1; OMOD1	0.00163132	0.10913689755053724
BALLER-GEROLD SYNDROME	0.00163132	0.10913689755053724
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.10913689755053724
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.10913689755053724
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.10913689755053724
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.10913689755053724
FRAXE INTELLECTUAL DISABILITY	0.00163132	0.10913689755053724
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.10913689755053724
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.10913689755053724
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.10913689755053724
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.10913689755053724
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.10913689755053724
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.10913689755053724
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00163132	0.10913689755053724
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.10913689755053724
GORLIN SYNDROME	0.00163132	0.10913689755053724
FRONTORHINY	0.00163132	0.10913689755053724
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.10913689755053724
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.10913689755053724
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.10913689755053724
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.10913689755053724
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.10913689755053724
BRADDOCK SYNDROME	0.00163132	0.10913689755053724
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.10913689755053724
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.10913689755053724
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.10913689755053724
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.10913689755053724
BRITTLE CORNEA SYNDROME	0.00163132	0.10913689755053724
HENNEKAM SYNDROME	0.00163132	0.10913689755053724
PENOSCROTAL TRANSPOSITION	0.00163132	0.10913689755053724
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.10913689755053724
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.10913689755053724
MECKEL SYNDROME, TYPE 10; MKS10	0.00163132	0.10913689755053724
ACRODYSOSTOSIS	0.00163132	0.10913689755053724
SCHOLTE SYNDROME; SHLTS	0.00163132	0.10913689755053724
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.10913689755053724
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.10913689755053724
RENAL AGENESIS, BILATERAL	0.00163132	0.10913689755053724
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.10913689755053724
JUBERG-MARSIDI SYNDROME	0.00163132	0.10913689755053724
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.10913689755053724
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.10913689755053724
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.10913689755053724
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00163132	0.10913689755053724
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.10913689755053724
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00163132	0.10913689755053724
SILLENCE SYNDROME	0.00163132	0.10913689755053724
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.10913689755053724
FETAL VALPROATE SYNDROME	0.00163132	0.10913689755053724
MOSAIC TRISOMY 9	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.08710399824708744
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001301984	0.08710399824708744
BETA-UREIDOPROPIONASE DEFICIENCY	0.001301984	0.08710399824708744
15Q14 MICRODELETION SYNDROME	0.001301984	0.08710399824708744
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001301984	0.08710399824708744
PETERS PLUS SYNDROME	0.001301984	0.08710399824708744
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.08710399824708744
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001301984	0.08710399824708744
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.08710399824708744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.08710399824708744
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708744
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001301984	0.08710399824708744
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.001301984	0.08710399824708744
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001301984	0.08710399824708744
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001301984	0.08710399824708744
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001301984	0.08710399824708744
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001301984	0.08710399824708744
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.001301984	0.08710399824708744
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.08710399824708744
MIETENS SYNDROME	0.001301984	0.08710399824708744
GLASS SYNDROME	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001301984	0.08710399824708744
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001301984	0.08710399824708744
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001301984	0.08710399824708744
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001301984	0.08710399824708744
XQ28 (MECP2) DUPLICATION	0.001301984	0.08710399824708744
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.08710399824708744
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708744
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.08710399824708744
ADAMS-OLIVER SYNDROME 1; AOS1	0.001301984	0.08710399824708744
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001301984	0.08710399824708744
HOLOPROSENCEPHALY 2; HPE2	0.001301984	0.08710399824708744
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001301984	0.08710399824708744
ROBERTS SYNDROME	0.001301984	0.08710399824708744
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001301984	0.08710399824708744
RUVALCABA SYNDROME	0.001301984	0.08710399824708744
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001301984	0.08710399824708744
16P13.11 MICRODELETION SYNDROME	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001301984	0.08710399824708744
ALG11-CDG	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001301984	0.08710399824708744
CONGENITAL VARICELLA SYNDROME	0.001301984	0.08710399824708744
MEVALONIC ACIDURIA	0.001301984	0.08710399824708744
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001301984	0.08710399824708744
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001301984	0.08710399824708744
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.08710399824708744
COG4-CDG	0.001301984	0.08710399824708744
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708744
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708744
MEVALONIC ACIDURIA; MEVA	0.001301984	0.08710399824708744
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001301984	0.08710399824708744
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001301984	0.08710399824708744
MYHRE SYNDROME	0.001301984	0.08710399824708744
ALAZAMI SYNDROME; ALAZS	0.001301984	0.08710399824708744
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.08710399824708744
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.08710399824708744
LISSENCEPHALY 4	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001301984	0.08710399824708744
MARINESCO-SJÖGREN SYNDROME	0.001301984	0.08710399824708744
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001301984	0.08710399824708744
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.08710399824708744
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001301984	0.08710399824708744
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001301984	0.08710399824708744
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.08710399824708744
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001301984	0.08710399824708744
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.08710399824708744
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001301984	0.08710399824708744
SAY-BARBER-MILLER SYNDROME	0.001301984	0.08710399824708744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001301984	0.08710399824708744
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.08710399824708744
ADAMS-OLIVER SYNDROME 2; AOS2	0.001301984	0.08710399824708744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.08710399824708744
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.08710399824708744
TRISOMY 17P	0.001301984	0.08710399824708744
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.08710399824708744
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001301984	0.08710399824708744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.08710399824708744
LIG4 SYNDROME	0.001301984	0.08710399824708744
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001301984	0.08710399824708744
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.08710399824708744
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001301984	0.08710399824708744
KBG SYNDROME	0.001301984	0.08710399824708744
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001301984	0.08710399824708744
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001301984	0.08710399824708744
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.08710399824708744
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.08710399824708744
CLASSIC PHENYLKETONURIA	0.001301984	0.08710399824708744
KABUKI SYNDROME 1	0.001301984	0.08710399824708744
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.08710399824708744
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001301984	0.08710399824708744
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001301984	0.08710399824708744
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.08710399824708744
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001301984	0.08710399824708744
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001301984	0.08710399824708744
BRESEK SYNDROME	0.001301984	0.08710399824708744
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.08710399824708744
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001301984	0.08710399824708744
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.08710399824708744
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001301984	0.08710399824708744
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.08710399824708744
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.08710399824708744
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.08710399824708744
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001301984	0.08710399824708744
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.08710399824708744
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001301984	0.08710399824708744
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.08710399824708744
KLEEFSTRA SYNDROME 2; KLEFS2	0.001301984	0.08710399824708744
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708744
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001301984	0.08710399824708744
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001301984	0.08710399824708744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001301984	0.08710399824708744
CHROMOSOME 1P35 DELETION SYNDROME	0.001301984	0.08710399824708744
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001301984	0.08710399824708744
MACDERMOT-WINTER SYNDROME	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001301984	0.08710399824708744
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.08710399824708744
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.08710399824708744
LISSENCEPHALY 8; LIS8	0.001301984	0.08710399824708744
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001301984	0.08710399824708744
GENITOPATELLAR SYNDROME	0.001301984	0.08710399824708744
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.08710399824708744
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001301984	0.08710399824708744
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.08710399824708744
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.08710399824708744
OPTIC ATROPHY 11; OPA11	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001301984	0.08710399824708744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.08710399824708744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.08710399824708744
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001301984	0.08710399824708744
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001301984	0.08710399824708744
HOLOPROSENCEPHALY 1; HPE1	0.001301984	0.08710399824708744
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001301984	0.08710399824708744
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.08710399824708744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001301984	0.08710399824708744
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001301984	0.08710399824708744
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.08710399824708744
JABERI-ELAHI SYNDROME; JABELS	0.001301984	0.08710399824708744
GALLOWAY-MOWAT SYNDROME	0.001301984	0.08710399824708744
GALACTOSEMIA	0.001301984	0.08710399824708744
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001301984	0.08710399824708744
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.08710399824708744
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.08710399824708744
MUCOLIPIDOSIS IV; ML4	0.001301984	0.08710399824708744
17Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708744
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001301984	0.08710399824708744
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001301984	0.08710399824708744
WALKER-WARBURG SYNDROME	0.001301984	0.08710399824708744
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001301984	0.08710399824708744
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001301984	0.08710399824708744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001301984	0.08710399824708744
SSR4-CDG	0.001301984	0.08710399824708744
STT3B-CDG	0.001301984	0.08710399824708744
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001301984	0.08710399824708744
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001301984	0.08710399824708744
STT3A-CDG	0.001301984	0.08710399824708744
2Q37 MICRODELETION SYNDROME	0.001301984	0.08710399824708744
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001301984	0.08710399824708744
LISSENCEPHALY 2; LIS2	0.001301984	0.08710399824708744
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001301984	0.08710399824708744
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001301984	0.08710399824708744
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.08710399824708744
PENTASOMY X	0.001301984	0.08710399824708744
RAINE SYNDROME	0.001301984	0.08710399824708744
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001301984	0.08710399824708744
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.08710399824708744
SLC35A2-CDG	0.001301984	0.08710399824708744
DPAGT1-CDG	0.001301984	0.08710399824708744
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001301984	0.08710399824708744
MEHMO SYNDROME; MEHMO	0.001301984	0.08710399824708744
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001301984	0.08710399824708744
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001301984	0.08710399824708744
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.08710399824708744
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001301984	0.08710399824708744
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001301984	0.08710399824708744
CONGENITAL TOXOPLASMOSIS	0.001301984	0.08710399824708744
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.08710399824708744
DISTAL MONOSOMY 15Q	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001301984	0.08710399824708744
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001301984	0.08710399824708744
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001301984	0.08710399824708744
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.08710399824708744
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.08710399824708744
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001301984	0.08710399824708744
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001301984	0.08710399824708744
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.08710399824708744
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001301984	0.08710399824708744
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001301984	0.08710399824708744
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001301984	0.08710399824708744
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.08710399824708744
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.08710399824708744
AL-RAQAD SYNDROME; ARS	0.001301984	0.08710399824708744
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001301984	0.08710399824708744
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.08710399824708744
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.08710399824708744
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.08710399824708744
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.08710399824708744
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001301984	0.08710399824708744
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001301984	0.08710399824708744
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.08710399824708744
TRISOMY 9P	0.001301984	0.08710399824708744
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.08710399824708744
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.08710399824708744
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.08710399824708744
FILIPPI SYNDROME	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.001301984	0.08710399824708744
DUANE RETRACTION SYNDROME	0.001301984	0.08710399824708744
ROIFMAN SYNDROME; RFMN	0.001301984	0.08710399824708744
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.08710399824708744
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.08710399824708744
WIEACKER-WOLFF SYNDROME	0.001301984	0.08710399824708744
ALG1-CDG	0.001301984	0.08710399824708744
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708744
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001301984	0.08710399824708744
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001301984	0.08710399824708744
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.08710399824708744
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.08710399824708744
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.08710399824708744
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001301984	0.08710399824708744
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001301984	0.08710399824708744
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.08710399824708744
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001301984	0.08710399824708744
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.08710399824708744
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.08710399824708744
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.08710399824708744
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001301984	0.08710399824708744
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001301984	0.08710399824708744
MICRO SYNDROME	0.001301984	0.08710399824708744
MARDEN-WALKER SYNDROME	0.001301984	0.08710399824708744
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.001301984	0.08710399824708744
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.08710399824708744
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001301984	0.08710399824708744
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001301984	0.08710399824708744
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.08710399824708744
WHITE-SUTTON SYNDROME; WHSUS	0.001301984	0.08710399824708744
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.08710399824708744
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.08710399824708744
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001301984	0.08710399824708744
LOWRY-MACLEAN SYNDROME	0.001301984	0.08710399824708744
3Q29 MICRODUPLICATION SYNDROME	0.001301984	0.08710399824708744
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001301984	0.08710399824708744
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.08710399824708744
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001301984	0.08710399824708744
COFFIN-SIRIS SYNDROME 5	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001301984	0.08710399824708744
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001301984	0.08710399824708744
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.08710399824708744
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.08710399824708744
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.08710399824708744
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001301984	0.08710399824708744
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001301984	0.08710399824708744
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001301984	0.08710399824708744
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001301984	0.08710399824708744
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001301984	0.08710399824708744
SECKEL SYNDROME 8; SCKL8	0.001301984	0.08710399824708744
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001301984	0.08710399824708744
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001301984	0.08710399824708744
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001301984	0.08710399824708744
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001301984	0.08710399824708744
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001301984	0.08710399824708744
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001301984	0.08710399824708744
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001301984	0.08710399824708744
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.08710399824708744
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001301984	0.08710399824708744
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.08710399824708744
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.08710399824708744
HYPERTRICHOSIS CUBITI	0.001301984	0.08710399824708744
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001301984	0.08710399824708744
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.08710399824708744
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.08710399824708744
ALG3-CDG	0.001301984	0.08710399824708744
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001301984	0.08710399824708744
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.08710399824708744
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001301984	0.08710399824708744
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.08710399824708744
PELIZAEUS-MERZBACHER DISEASE	0.001301984	0.08710399824708744
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.08710399824708744
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.08710399824708744
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.050605904061835134
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.050605904061835134
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00075643	0.050605904061835134
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.050605904061835134
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.050605904061835134
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.050605904061835134
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00075643	0.050605904061835134
ERMINE PHENOTYPE	0.00075643	0.050605904061835134
PRIMARY CUTIS VERTICIS GYRATA	0.00075643	0.050605904061835134
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.050605904061835134
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.050605904061835134
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.050605904061835134
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.050605904061835134
ROIFMAN SYNDROME	0.00075643	0.050605904061835134
MMEP SYNDROME	0.00075643	0.050605904061835134
MECKEL SYNDROME	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00075643	0.050605904061835134
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00075643	0.050605904061835134
CAMOS SYNDROME	0.00075643	0.050605904061835134
MICROPHTHALMIA, LENZ TYPE	0.00075643	0.050605904061835134
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.050605904061835134
WEAVER-WILLIAMS SYNDROME	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.050605904061835134
STIMMLER SYNDROME	0.00075643	0.050605904061835134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.050605904061835134
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.050605904061835134
PAGOD SYNDROME	0.00075643	0.050605904061835134
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.050605904061835134
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.050605904061835134
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.050605904061835134
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00075643	0.050605904061835134
TETRAPLOIDY	0.00075643	0.050605904061835134
WORSTER-DROUGHT SYNDROME	0.00075643	0.050605904061835134
ANGELMAN SYNDROME	0.00075643	0.050605904061835134
SJÖGREN-LARSSON SYNDROME	0.00075643	0.050605904061835134
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00075643	0.050605904061835134
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.050605904061835134
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.050605904061835134
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.050605904061835134
SATOYOSHI SYNDROME	0.00075643	0.050605904061835134
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.050605904061835134
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.050605904061835134
SCHISIS ASSOCIATION	0.00075643	0.050605904061835134
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.050605904061835134
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.050605904061835134
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.050605904061835134
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00075643	0.050605904061835134
XK APROSENCEPHALY SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.050605904061835134
WAGR SYNDROME	0.00075643	0.050605904061835134
WOLF-HIRSCHHORN SYNDROME	0.00075643	0.050605904061835134
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.050605904061835134
SECKEL SYNDROME 10; SCKL10	0.00075643	0.050605904061835134
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00075643	0.050605904061835134
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.050605904061835134
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.050605904061835134
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.050605904061835134
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.050605904061835134
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.050605904061835134
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.050605904061835134
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00075643	0.050605904061835134
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.050605904061835134
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00075643	0.050605904061835134
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.050605904061835134
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00075643	0.050605904061835134
PHENYLKETONURIA	0.00075643	0.050605904061835134
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00075643	0.050605904061835134
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.050605904061835134
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00075643	0.050605904061835134
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.050605904061835134
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.050605904061835134
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.050605904061835134
RHIZOMELIC SYNDROME	0.00075643	0.050605904061835134
ROBERTS SYNDROME; RBS	0.00075643	0.050605904061835134
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.050605904061835134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.050605904061835134
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00075643	0.050605904061835134
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.050605904061835134
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.050605904061835134
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00075643	0.050605904061835134
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.050605904061835134
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.050605904061835134
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.050605904061835134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.050605904061835134
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.050605904061835134
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.050605904061835134
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.050605904061835134
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00075643	0.050605904061835134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.050605904061835134
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.050605904061835134
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.050605904061835134
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.050605904061835134
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00075643	0.050605904061835134
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.050605904061835134
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.050605904061835134
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.050605904061835134
FEINGOLD SYNDROME	0.00075643	0.050605904061835134
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.050605904061835134
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.050605904061835134
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.050605904061835134
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.050605904061835134
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.050605904061835134
BLOOM SYNDROME	0.00075643	0.050605904061835134
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.050605904061835134
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00075643	0.050605904061835134
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.050605904061835134
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.050605904061835134
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.050605904061835134
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.050605904061835134
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.050605904061835134
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.050605904061835134
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.050605904061835134
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.050605904061835134
OTOMANDIBULAR SYNDROME	0.00075643	0.050605904061835134
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.050605904061835134
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.050605904061835134
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.050605904061835134
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00075643	0.050605904061835134
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00075643	0.050605904061835134
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00075643	0.050605904061835134
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.050605904061835134
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.050605904061835134
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.050605904061835134
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.050605904061835134
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.050605904061835134
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.050605904061835134
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.050605904061835134
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00075643	0.050605904061835134
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00075643	0.050605904061835134
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.050605904061835134
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.050605904061835134
LAMBOTTE SYNDROME	0.00075643	0.050605904061835134
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.050605904061835134
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.050605904061835134
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.050605904061835134
STROMME SYNDROME; STROMS	0.00075643	0.050605904061835134
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.050605904061835134
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.050605904061835134
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.050605904061835134
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00075643	0.050605904061835134
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00075643	0.050605904061835134
LISSENCEPHALY 3; LIS3	0.00075643	0.050605904061835134
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.050605904061835134
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00075643	0.050605904061835134
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.050605904061835134
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.050605904061835134
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.050605904061835134
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.050605904061835134
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.050605904061835134
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.050605904061835134
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.050605904061835134
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.050605904061835134
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00075643	0.050605904061835134
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.050605904061835134
GAUCHER DISEASE, PERINATAL LETHAL	0.00075643	0.050605904061835134
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.050605904061835134
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00075643	0.050605904061835134
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.050605904061835134
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.050605904061835134
SECKEL SYNDROME 5; SCKL5	0.00075643	0.050605904061835134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00075643	0.050605904061835134
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.050605904061835134
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00075643	0.050605904061835134
SECKEL SYNDROME 4	0.00075643	0.050605904061835134
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.050605904061835134
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.050605904061835134
FACIOCARDIOMELIC SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.050605904061835134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.050605904061835134
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.050605904061835134
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.050605904061835134
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.050605904061835134
PERRAULT SYNDROME 3	0.00075643	0.050605904061835134
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00075643	0.050605904061835134
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.050605904061835134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.050605904061835134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.050605904061835134
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00075643	0.050605904061835134
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.050605904061835134
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.050605904061835134
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00075643	0.050605904061835134
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00075643	0.050605904061835134
INCONTINENTIA PIGMENTI; IP	0.00075643	0.050605904061835134
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.050605904061835134
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.050605904061835134
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.050605904061835134
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00075643	0.050605904061835134
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.050605904061835134
AICARDI SYNDROME; AIC	0.00075643	0.050605904061835134
MASA SYNDROME	0.00075643	0.050605904061835134
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00075643	0.050605904061835134
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.050605904061835134
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00075643	0.050605904061835134
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00075643	0.050605904061835134
BARDET-BIEDL SYNDROME 20	0.00075643	0.050605904061835134
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00075643	0.050605904061835134
MENTAL RETARDATION, X-LINKED 102	0.00075643	0.050605904061835134
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00075643	0.050605904061835134
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.050605904061835134
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.050605904061835134
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.050605904061835134
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00075643	0.050605904061835134
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.050605904061835134
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.050605904061835134
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.050605904061835134
MECKEL SYNDROME 12; MKS12	0.00075643	0.050605904061835134
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.050605904061835134
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.050605904061835134
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.050605904061835134
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00075643	0.050605904061835134
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.050605904061835134
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.050605904061835134
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00075643	0.050605904061835134
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00075643	0.050605904061835134
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.050605904061835134
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.050605904061835134
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00075643	0.050605904061835134
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.050605904061835134
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.050605904061835134
CYCLIC VOMITING SYNDROME	0.00075643	0.050605904061835134
PAINE SYNDROME	0.00075643	0.050605904061835134
RING CHROMOSOME 1 SYNDROME	0.00075643	0.050605904061835134
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.050605904061835134
HYPERREFLEXIA	0.00075643	0.050605904061835134
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.050605904061835134
CHARGE SYNDROME	0.00075643	0.050605904061835134
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.050605904061835134
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00075643	0.050605904061835134
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.050605904061835134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00075643	0.050605904061835134
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.050605904061835134
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.050605904061835134
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.050605904061835134
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.050605904061835134
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.050605904061835134
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.050605904061835134
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.050605904061835134
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00075643	0.050605904061835134
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.050605904061835134
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.050605904061835134
HARROD SYNDROME	0.00075643	0.050605904061835134
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.050605904061835134
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00075643	0.050605904061835134
FRASER SYNDROME	0.00075643	0.050605904061835134
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.050605904061835134
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.050605904061835134
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.050605904061835134
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.050605904061835134
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.050605904061835134
BRANCHIOOCULOFACIAL SYNDROME	0.00075643	0.050605904061835134
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.050605904061835134
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.050605904061835134
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.050605904061835134
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00075643	0.050605904061835134
TYROSINEMIA TYPE 2	0.00075643	0.050605904061835134
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.050605904061835134
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.050605904061835134
VELOCARDIOFACIAL SYNDROME	0.00075643	0.050605904061835134
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.050605904061835134
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00075643	0.050605904061835134
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.050605904061835134
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.050605904061835134
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.050605904061835134
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.050605904061835134
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.050605904061835134
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.050605904061835134
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.050605904061835134
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.050605904061835134
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.050605904061835134
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00075643	0.050605904061835134
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.050605904061835134
JUBERG-HAYWARD SYNDROME	0.00075643	0.050605904061835134
JUNG SYNDROME	0.00075643	0.050605904061835134
KABUKI SYNDROME	0.00075643	0.050605904061835134
SANJAD-SAKATI SYNDROME	0.00075643	0.050605904061835134
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.050605904061835134
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.050605904061835134
BOWEN-CONRADI SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00075643	0.050605904061835134
BANGSTAD SYNDROME	0.00075643	0.050605904061835134
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00075643	0.050605904061835134
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.050605904061835134
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.050605904061835134
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.050605904061835134
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00075643	0.050605904061835134
5Q35 MICRODUPLICATION SYNDROME	0.00075643	0.050605904061835134
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.050605904061835134
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.050605904061835134
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.050605904061835134
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.050605904061835134
MICROFORM HOLOPROSENCEPHALY	0.00075643	0.050605904061835134
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.050605904061835134
MOYNAHAN SYNDROME	0.00075643	0.050605904061835134
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.050605904061835134
SUPRABULBAR PARESIS, CONGENITAL	0.00075643	0.050605904061835134
RUVALCABA SYNDROME	0.00075643	0.050605904061835134
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.050605904061835134
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.050605904061835134
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.050605904061835134
ANGELMAN SYNDROME (TYPE 1)	0.00075643	0.050605904061835134
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.050605904061835134
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.050605904061835134
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00075643	0.050605904061835134
NON-DISTAL TRISOMY 10Q	0.00075643	0.050605904061835134
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.050605904061835134
DISTAL TRISOMY 15Q	0.00075643	0.050605904061835134
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.050605904061835134
PSEUDOPROGERIA SYNDROME	0.00075643	0.050605904061835134
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.050605904061835134
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.050605904061835134
LEUKOCYTE ADHESION DEFICIENCY	0.00075643	0.050605904061835134
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.050605904061835134
RENAL TUBULAR DYSGENESIS	0.00075643	0.050605904061835134
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.050605904061835134
DISTAL MONOSOMY 13Q	0.00075643	0.050605904061835134
FANCONI ANEMIA	0.00075643	0.050605904061835134
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00075643	0.050605904061835134
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.050605904061835134
CRANIOFRONTONASAL DYSPLASIA	0.00075643	0.050605904061835134
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00075643	0.050605904061835134
ANE SYNDROME	0.00075643	0.050605904061835134
DISTAL MONOSOMY 17Q	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.050605904061835134
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.050605904061835134
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.050605904061835134
COG5-CDG	0.00075643	0.050605904061835134
DISTAL MONOSOMY 7Q36	0.00075643	0.050605904061835134
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.050605904061835134
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.050605904061835134
NEU-LAXOVA SYNDROME	0.00075643	0.050605904061835134
ANGELMAN SYNDROME (TYPE 2)	0.00075643	0.050605904061835134
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.050605904061835134
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.050605904061835134
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.050605904061835134
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00075643	0.050605904061835134
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.050605904061835134
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.050605904061835134
CONGENITAL RUBELLA SYNDROME	0.00075643	0.050605904061835134
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.050605904061835134
DIABETIC EMBRYOPATHY	0.00075643	0.050605904061835134
FETAL METHYLMERCURY SYNDROME	0.00075643	0.050605904061835134
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.050605904061835134
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.050605904061835134
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.050605904061835134
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.050605904061835134
POLAND SYNDROME	0.00075643	0.050605904061835134
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.050605904061835134
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.050605904061835134
LOWRY-WOOD SYNDROME	0.00075643	0.050605904061835134
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.050605904061835134
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.050605904061835134
OLIVER SYNDROME	0.00075643	0.050605904061835134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.03649809418525231
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.03649809418525231
PHACE ASSOCIATION	0.000545554	0.03649809418525231
HURLER SYNDROME	0.000545554	0.03649809418525231
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.03649809418525231
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.03649809418525231
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.03649809418525231
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.03649809418525231
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.03649809418525231
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.03649809418525231
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.03649809418525231
ALG6-CDG	0.000545554	0.03649809418525231
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.03649809418525231
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.03649809418525231
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.03649809418525231
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.03649809418525231
NOONAN SYNDROME 2; NS2	0.000545554	0.03649809418525231
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.03649809418525231
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.03649809418525231
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.03649809418525231
CHAR SYNDROME	0.000545554	0.03649809418525231
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.03649809418525231
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.03649809418525231
CURRY-JONES SYNDROME	0.000545554	0.03649809418525231
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.03649809418525231
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.03649809418525231
PELGER-HUET ANOMALY; PHA	0.000545554	0.03649809418525231
CDAGS SYNDROME	0.000545554	0.03649809418525231
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.03649809418525231
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.03649809418525231
JOUBERT SYNDROME 7	0.000545554	0.03649809418525231
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.03649809418525231
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.03649809418525231
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.03649809418525231
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.03649809418525231
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.03649809418525231
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.03649809418525231
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.03649809418525231
8P23.1 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.03649809418525231
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 8	0.000545554	0.03649809418525231
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.03649809418525231
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.03649809418525231
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.03649809418525231
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.03649809418525231
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.03649809418525231
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.03649809418525231
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.03649809418525231
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.03649809418525231
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.03649809418525231
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.03649809418525231
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.03649809418525231
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.03649809418525231
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.03649809418525231
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.03649809418525231
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.03649809418525231
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.03649809418525231
HOLOPROSENCEPHALY 7	0.000545554	0.03649809418525231
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.03649809418525231
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.03649809418525231
JOUBERT SYNDROME 2	0.000545554	0.03649809418525231
KAGAMI-OGATA SYNDROME	0.000545554	0.03649809418525231
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.03649809418525231
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.03649809418525231
INFANTILE REFSUM DISEASE	0.000545554	0.03649809418525231
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.03649809418525231
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.03649809418525231
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.03649809418525231
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.03649809418525231
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.03649809418525231
FRIAS SYNDROME	0.000545554	0.03649809418525231
PALLISTER-HALL SYNDROME	0.000545554	0.03649809418525231
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.03649809418525231
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.03649809418525231
WOLMAN DISEASE	0.000545554	0.03649809418525231
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.03649809418525231
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.03649809418525231
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.03649809418525231
PRADER-WILLI SYNDROME; PWS	0.000545554	0.03649809418525231
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.03649809418525231
JOUBERT SYNDROME 6	0.000545554	0.03649809418525231
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.03649809418525231
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.03649809418525231
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.03649809418525231
CURRARINO SYNDROME	0.000545554	0.03649809418525231
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.03649809418525231
ELEJALDE DISEASE	0.000545554	0.03649809418525231
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.03649809418525231
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.03649809418525231
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.03649809418525231
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.03649809418525231
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.03649809418525231
OROTIC ACIDURIA	0.000545554	0.03649809418525231
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.03649809418525231
DISTAL MONOSOMY 19P13.3	0.000545554	0.03649809418525231
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.03649809418525231
PELLAGRA-LIKE SYNDROME	0.000545554	0.03649809418525231
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.03649809418525231
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.03649809418525231
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.03649809418525231
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.03649809418525231
COACH SYNDROME	0.000545554	0.03649809418525231
RECOMBINANT 8 SYNDROME	0.000545554	0.03649809418525231
ARGININEMIA	0.000545554	0.03649809418525231
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.03649809418525231
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.03649809418525231
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.03649809418525231
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.03649809418525231
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.03649809418525231
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.03649809418525231
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.03649809418525231
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.03649809418525231
SIALIDOSIS TYPE 2	0.000545554	0.03649809418525231
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.03649809418525231
THYROID HYPOPLASIA	0.000545554	0.03649809418525231
SULFOCYSTEINURIA	0.000545554	0.03649809418525231
HURLER SYNDROME	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.03649809418525231
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.03649809418525231
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.03649809418525231
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.03649809418525231
HARTNUP DISORDER	0.000545554	0.03649809418525231
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.03649809418525231
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.03649809418525231
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.03649809418525231
HYPERPROLINEMIA, TYPE I	0.000545554	0.03649809418525231
THYROID ECTOPIA	0.000545554	0.03649809418525231
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.03649809418525231
ATHYREOSIS	0.000545554	0.03649809418525231
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.03649809418525231
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.03649809418525231
ARIMA SYNDROME	0.000545554	0.03649809418525231
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.03649809418525231
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.03649809418525231
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.03649809418525231
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.03649809418525231
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.03649809418525231
KETOADIPICACIDURIA	0.000545554	0.03649809418525231
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.03649809418525231
LANDAU-KLEFFNER SYNDROME	0.000545554	0.03649809418525231
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.03649809418525231
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.03649809418525231
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.03649809418525231
PFEIFFER SYNDROME TYPE 2	0.000545554	0.03649809418525231
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.03649809418525231
THYROID HEMIAGENESIS	0.000545554	0.03649809418525231
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.03649809418525231
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.03649809418525231
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.03649809418525231
WAISMAN SYNDROME; WSMN	0.000545554	0.03649809418525231
ALSTROM SYNDROME; ALMS	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.03649809418525231
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.03649809418525231
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.03649809418525231
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.03649809418525231
GAUCHER DISEASE, TYPE II	0.000545554	0.03649809418525231
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.03649809418525231
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.03649809418525231
SYNDROMIC DIARRHEA	0.000545554	0.03649809418525231
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.03649809418525231
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.03649809418525231
TARP SYNDROME; TARPS	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.03649809418525231
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.03649809418525231
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.03649809418525231
CODAS SYNDROME	0.000545554	0.03649809418525231
SEPTOOPTIC DYSPLASIA	0.000545554	0.03649809418525231
SCHIZENCEPHALY	0.000545554	0.03649809418525231
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.03649809418525231
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.03649809418525231
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.03649809418525231
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.03649809418525231
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.03649809418525231
TIMOTHY SYNDROME; TS	0.000545554	0.03649809418525231
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.03649809418525231
KEUTEL SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.03649809418525231
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.03649809418525231
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.03649809418525231
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.03649809418525231
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.03649809418525231
AUSTRALIA ANTIGEN	0.000545554	0.03649809418525231
WAARDENBURG-SHAH SYNDROME	0.000545554	0.03649809418525231
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.03649809418525231
ZEBRA BODY MYOPATHY	0.000545554	0.03649809418525231
TREACHER-COLLINS SYNDROME	0.000545554	0.03649809418525231
RIGID SPINE SYNDROME	0.000545554	0.03649809418525231
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.03649809418525231
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.03649809418525231
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.03649809418525231
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.03649809418525231
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.03649809418525231
ARGININOSUCCINIC ACIDURIA	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.03649809418525231
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.03649809418525231
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.03649809418525231
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.03649809418525231
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.03649809418525231
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.03649809418525231
MEND SYNDROME; MEND	0.000545554	0.03649809418525231
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.03649809418525231
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.03649809418525231
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
NOONAN SYNDROME 11; NS11	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.03649809418525231
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.03649809418525231
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.03649809418525231
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.03649809418525231
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.03649809418525231
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.03649809418525231
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.03649809418525231
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.03649809418525231
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.03649809418525231
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.03649809418525231
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.03649809418525231
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.03649809418525231
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.03649809418525231
TRANSALDOLASE DEFICIENCY	0.000545554	0.03649809418525231
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.03649809418525231
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.03649809418525231
FUCOSIDOSIS	0.000545554	0.03649809418525231
PROPIONIC ACIDEMIA	0.000545554	0.03649809418525231
ISOLATED PLAGIOCEPHALY	0.000545554	0.03649809418525231
DEXTROCARDIA	0.000545554	0.03649809418525231
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.03649809418525231
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.03649809418525231
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.03649809418525231
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.03649809418525231
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.03649809418525231
CINCA SYNDROME	0.000545554	0.03649809418525231
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.03649809418525231
XQ21 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
AURICULOCONDYLAR SYNDROME	0.000545554	0.03649809418525231
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.03649809418525231
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.03649809418525231
AYMÉ-GRIPP SYNDROME	0.000545554	0.03649809418525231
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.03649809418525231
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.03649809418525231
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.03649809418525231
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.03649809418525231
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.03649809418525231
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.03649809418525231
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
DYSTONIA-APHONIA SYNDROME	0.000545554	0.03649809418525231
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.03649809418525231
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.03649809418525231
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.03649809418525231
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.03649809418525231
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.03649809418525231
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.03649809418525231
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.03649809418525231
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.03649809418525231
MEND SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.03649809418525231
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.03649809418525231
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.03649809418525231
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.03649809418525231
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.03649809418525231
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.03649809418525231
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.03649809418525231
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.03649809418525231
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.03649809418525231
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.03649809418525231
MOSAIC TRISOMY 14	0.000545554	0.03649809418525231
DISTAL TRISOMY 18Q	0.000545554	0.03649809418525231
TRISOMY 8Q	0.000545554	0.03649809418525231
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.03649809418525231
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.03649809418525231
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.03649809418525231
OTOFACIOCERVICAL SYNDROME	0.000545554	0.03649809418525231
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.03649809418525231
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.03649809418525231
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.03649809418525231
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.03649809418525231
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.03649809418525231
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.03649809418525231
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.03649809418525231
WILSON-TURNER SYNDROME	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.03649809418525231
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.03649809418525231
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.03649809418525231
17Q12 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.03649809418525231
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.03649809418525231
W SYNDROME	0.000545554	0.03649809418525231
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.03649809418525231
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.03649809418525231
HEREDITARY OROTIC ACIDURIA	0.000545554	0.03649809418525231
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.03649809418525231
1P21.3 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.03649809418525231
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.03649809418525231
TARP SYNDROME	0.000545554	0.03649809418525231
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.03649809418525231
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.03649809418525231
SEVERE CANAVAN DISEASE	0.000545554	0.03649809418525231
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.03649809418525231
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.03649809418525231
SENIOR-LOKEN SYNDROME	0.000545554	0.03649809418525231
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.03649809418525231
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.03649809418525231
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.03649809418525231
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.03649809418525231
DONNAI-BARROW SYNDROME	0.000545554	0.03649809418525231
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.03649809418525231
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.03649809418525231
HARTNUP DISEASE	0.000545554	0.03649809418525231
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.03649809418525231
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.03649809418525231
GERODERMA OSTEODYSPLASTICA	0.000545554	0.03649809418525231
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.03649809418525231
COLE-CARPENTER SYNDROME	0.000545554	0.03649809418525231
FLOATING-HARBOR SYNDROME	0.000545554	0.03649809418525231
COWDEN SYNDROME	0.000545554	0.03649809418525231
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.03649809418525231
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.03649809418525231
EAST SYNDROME	0.000545554	0.03649809418525231
WEAVER SYNDROME	0.000545554	0.03649809418525231
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.03649809418525231
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.03649809418525231
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.03649809418525231
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.03649809418525231
ZECHI-CEIDE SYNDROME	0.000545554	0.03649809418525231
CITRULLINEMIA TYPE II	0.000545554	0.03649809418525231
FARBER DISEASE	0.000545554	0.03649809418525231
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.03649809418525231
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.03649809418525231
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.03649809418525231
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.03649809418525231
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.03649809418525231
USHER SYNDROME TYPE 1	0.000545554	0.03649809418525231
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.03649809418525231
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.03649809418525231
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.03649809418525231
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.03649809418525231
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.03649809418525231
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.03649809418525231
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.03649809418525231
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.03649809418525231
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.03649809418525231
LEBER CONGENITAL AMAUROSIS	0.000545554	0.03649809418525231
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.03649809418525231
XIA-GIBBS SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.03649809418525231
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.03649809418525231
MAPLE SYRUP URINE DISEASE	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.03649809418525231
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.03649809418525231
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.03649809418525231
JOUBERT SYNDROME 21	0.000545554	0.03649809418525231
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.03649809418525231
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.03649809418525231
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.03649809418525231
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.03649809418525231
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.03649809418525231
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.03649809418525231
CULLER-JONES SYNDROME; CJS	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.03649809418525231
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.03649809418525231
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.03649809418525231
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.03649809418525231
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.03649809418525231
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.03649809418525231
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.03649809418525231
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.03649809418525231
BARDET-BIEDL SYNDROME 2	0.000545554	0.03649809418525231
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.03649809418525231
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.03649809418525231
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.03649809418525231
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.03649809418525231
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.03649809418525231
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.03649809418525231
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.03649809418525231
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.03649809418525231
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.03649809418525231
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.03649809418525231
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.03649809418525231
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.03649809418525231
MEDULLOBLASTOMA	0.000545554	0.03649809418525231
NETHERTON SYNDROME	0.000545554	0.03649809418525231
STEEL SYNDROME; STLS	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.03649809418525231
ALSTRÖM SYNDROME	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.03649809418525231
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.03649809418525231
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.03649809418525231
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.03649809418525231
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.03649809418525231
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 15	0.000545554	0.03649809418525231
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.03649809418525231
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.03649809418525231
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.03649809418525231
WYBURN-MASON SYNDROME	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.03649809418525231
CRANIOPHARYNGIOMA	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.03649809418525231
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.03649809418525231
ATELOSTEOGENESIS TYPE III	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.03649809418525231
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.03649809418525231
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.03649809418525231
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.03649809418525231
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.03649809418525231
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.03649809418525231
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.03649809418525231
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.03649809418525231
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.03649809418525231
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.03649809418525231
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.03649809418525231
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.03649809418525231
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.03649809418525231
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.03649809418525231
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.03649809418525231
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.03649809418525231
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.03649809418525231
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.03649809418525231
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.03649809418525231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.03649809418525231
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.03649809418525231
JOUBERT SYNDROME 28	0.000545554	0.03649809418525231
JOUBERT SYNDROME 27	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.03649809418525231
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.03649809418525231
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.03649809418525231
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.03649809418525231
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.03649809418525231
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.03649809418525231
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.03649809418525231
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.03649809418525231
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.03649809418525231
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.03649809418525231
MECKEL SYNDROME 13; MKS13	0.000545554	0.03649809418525231
SOTOS SYNDROME	0.000545554	0.03649809418525231
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.03649809418525231
RAHMAN SYNDROME	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.03649809418525231
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.03649809418525231
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.03649809418525231
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.03649809418525231
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.03649809418525231
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.03649809418525231
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.03649809418525231
MIRAGE SYNDROME; MIRAGE	0.000545554	0.03649809418525231
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.03649809418525231
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.03649809418525231
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.03649809418525231
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.03649809418525231
SENIOR-LOKEN SYNDROME 9	0.000545554	0.03649809418525231
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.03649809418525231
AU-KLINE SYNDROME; AUKS	0.000545554	0.03649809418525231
NOONAN SYNDROME 9; NS9	0.000545554	0.03649809418525231
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.03649809418525231
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.03649809418525231
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.03649809418525231
TRANSKETOLASE DEFICIENCY	0.000545554	0.03649809418525231
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.03649809418525231
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.03649809418525231
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.03649809418525231
CHOPS SYNDROME; CHOPS	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.03649809418525231
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.03649809418525231
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.03649809418525231
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.03649809418525231
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.03649809418525231
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.03649809418525231
CHAR SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.03649809418525231
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.03649809418525231
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.03649809418525231
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.03649809418525231
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.03649809418525231
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.03649809418525231
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.03649809418525231
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.03649809418525231
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000545554	0.03649809418525231
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.03649809418525231
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.03649809418525231
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.03649809418525231
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.03649809418525231
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.03649809418525231
JOUBERT SYNDROME 26	0.000545554	0.03649809418525231
JOUBERT SYNDROME 25	0.000545554	0.03649809418525231
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.03649809418525231
